content,keywords,test_description,title,"{""raw"":""You are a scientist with copy-editing skills tasked with refining the text of a scientific manuscript. Your goal is to revise the following paragraph from the Introduction section.\n\nInput paragraph: {{ content }}\n\nRevised paragraph:\n"",""display"":""/home/miltondp/projects/others/manubot/manubot-ai-editor-evals/introduction/prompts/baseline.txt"",""id"":""5bdeda8c1446401148c885c42e0f01b3ef31c1df7679dc5913891286599141ba"",""provider"":""exec:python /home/miltondp/projects/others/manubot/manubot-ai-editor-evals/src/llm.py --update-cache --model ollama=mixtral-8x22b-instruct-v0.1-q5_1"",""metrics"":{""score"":8.544642857142858,""testPassCount"":12,""testFailCount"":8,""assertPassCount"":134,""assertFailCount"":11,""totalLatencyMs"":7629417,""tokenUsage"":{""total"":0,""prompt"":0,""completion"":0,""cached"":0},""namedScores"":{},""cost"":0}}","{""raw"":""You are a scientist with copy-editing skills tasked with refining the text of a scientific manuscript titled '{{ title }}' with keywords '{{ keywords }}.' Your goal is to revise the following paragraph from the Introduction section to enhance clarity, reduce jargon, and maintain a scholarly tone. The revision should adhere to Markdown formatting and follow a Context-Content-Conclusion (C-C-C) structure. This structure begins by setting the stage with one or two sentences (Context), progresses through what is known from the literature (Content), and concludes by highlighting an aspect of the knowledge gap the manuscript addresses (Conclusion). Your revision should: 1) preserve the original information as much as possible, with minimal changes to the text, 2) ensure most references to scientific articles are kept exactly as they appear in the original text; these references are crucial for academic integrity and may appear with the format \""[@TYPE:ID]\"" such as \""[@pmid:33931583; @doi:10.1101/2021.10.21.21265225; @pmid:31036433]\"", and 4) the revised paragraph must encapsulate the entire revision, following the C-C-C structure, within a single, cohesive paragraph.\n\nInput paragraph: {{ content }}\n\nRevised paragraph:\n"",""display"":""/home/miltondp/projects/others/manubot/manubot-ai-editor-evals/introduction/prompts/candidate_with_metadata.txt"",""id"":""b3ae9b36dde69fd3a88b2596cb227a7e2c5b759aa55a7df82cafefe336d2dba2"",""provider"":""exec:python /home/miltondp/projects/others/manubot/manubot-ai-editor-evals/src/llm.py --update-cache --model ollama=mixtral-8x22b-instruct-v0.1-q5_1"",""metrics"":{""score"":9.758928571428571,""testPassCount"":15,""testFailCount"":5,""assertPassCount"":140,""assertFailCount"":5,""totalLatencyMs"":7753777,""tokenUsage"":{""total"":0,""prompt"":0,""completion"":0,""cached"":0},""namedScores"":{},""cost"":0}}","{""raw"":""You are a scientist with copy-editing skills tasked with refining the text of a scientific manuscript. Your goal is to revise the following paragraph from the Introduction section to enhance clarity, reduce jargon, and maintain a scholarly tone. The revision should adhere to Markdown formatting and follow a Context-Content-Conclusion (C-C-C) structure. This structure begins by setting the stage with one or two sentences (Context), progresses through what is known from the literature (Content), and concludes by highlighting an aspect of the knowledge gap the manuscript addresses (Conclusion). Your revision should: 1) preserve the original information as much as possible, with minimal changes to the text, 2) ensure most references to scientific articles are kept exactly as they appear in the original text; these references are crucial for academic integrity and may appear with the format \""[@TYPE:ID]\"" such as \""[@pmid:33931583; @doi:10.1101/2021.10.21.21265225; @pmid:31036433]\"", and 4) the revised paragraph must encapsulate the entire revision, following the C-C-C structure, within a single, cohesive paragraph.\n\nInput paragraph: {{ content }}\n\nRevised paragraph:\n"",""display"":""/home/miltondp/projects/others/manubot/manubot-ai-editor-evals/introduction/prompts/candidate.txt"",""id"":""fdcb2dbde0cdbdbfbd3bef849b82148735a55ce5adb62ddee51c9c41a40f7876"",""provider"":""exec:python /home/miltondp/projects/others/manubot/manubot-ai-editor-evals/src/llm.py --update-cache --model ollama=mixtral-8x22b-instruct-v0.1-q5_1"",""metrics"":{""score"":10.008928571428573,""testPassCount"":16,""testFailCount"":4,""assertPassCount"":140,""assertFailCount"":5,""totalLatencyMs"":7230580,""tokenUsage"":{""total"":0,""prompt"":0,""completion"":0,""cached"":0},""namedScores"":{},""cost"":0}}"
"Genes work together in context-specific networks to karry out different functions [@pmid:19104045; @doi:10.1038/ng.3259]. Variations in these genes can change their functional role and, at a higher level, affect disease-relevant biological processes [@doi:10.1038/s41467-018-06022-6]. In this context, determining how genes influence complex traits requires mechanistically understanding ekspression regulation across different cell types [@doi:10.1126/science.aaz1776; @doi:10.1038/s41586-020-2559-3; @doi:10.1038/s41576-019-0200-9], which in turn should lead to improved treatments [@doi:10.1038/ng.3314; @doi:10.1371/journal.pgen.1008489]. Previous studies has described different regulatory DNA elements [@doi:10.1038/nature11247; @doi:10.1038/nature14248; @doi:10.1038/nature12787; @doi:10.1038/s41586-020-03145-z; @doi:10.1038/s41586-020-2559-3] including genetic effects on gene expression across different tissues [@doi:10.1126/science.aaz1776]. Integrating functional genomics data and GWAS data [@doi:10.1038/s41588-018-0081-4; @doi:10.1016/j.ajhg.2018.04.002; @doi:10.1038/s41588-018-0081-4; @doi:10.1038/ncomms6890] has improoved the identification of these transcriptional mechanisms that, when dysregulated, commonly result in tissue- and cell lineage-specific pathology [@pmid:20624743; @pmid:14707169; @doi:10.1073/pnas.0810772105].","genetic studies, functional genomics, gene co-expression, therapeutic targets, drug repurposing, clustering of complex traits",Has no spelling errors,Projecting genetic associations through gene expression patterns highlights disease etiology and drug mechanisms,"[PASS] (0.50)

Genes interact in context-specific networks to carry out various functions [@pmid:19104045; @doi:10.1038/ng.3259]. Variations in these genes can alter their functional role and, at a higher level, impact disease-relevant biological processes [@doi:10.1038/s41467-018-06022-6]. In this context, understanding how genes influence complex traits requires mechanistically comprehending expression regulation across different cell types [@doi:10.1126/science.aaz1776; @doi:10.1038/s41586-020-2559-3; @doi:10.1038/s41576-019-0200-9], which should ultimately lead to improved treatments [@doi:10.1038/ng.3314; @doi:10.1371/journal.pgen.1008489]. Previous studies have described various regulatory DNA elements [@doi:10.1038/nature11247; @doi:10.1038/natire14248; @doi:10.1038/nature12787; @doi:10.1038/s41586-020-03145-z; @doi:10.1038/s41586-020-2559-3], including genetic effects on gene expression across different tissues [@doi:10.1126/science.aaz1776]. Integrating functional genomics data and GWAS data [@doi:10.1038/s41588-018-0081-4; @doi:10.1016/j.ajhg.2018.04.002; @doi:10.1038/s41588-018-0081-4; @doi:10.1038/ncumm96890] has improved the identification of these transcriptional mechanisms that, when dysregulated, commonly result in tissue- and cell lineage-specific pathology [@pmid:20624743; @pmid:14707169; @doi:10.1073/pnas.0810772105].

Pass Reason: All assertions passed","[PASS] (0.50)

Genes collaborate in context-specific networks to perform various functions [@pmid:19104045; @doi:10.1038/ng.3259]. Variations within these genes can alter their functional roles and, consequently, impact disease-relevant biological processes [@doi:10.1038/s41467-018-06022-6]. Understanding how genes influence complex traits necessitates a mechanistic understanding of expression regulation across different cell types [@doi:10.1126/science.aaz1776; @doi:10.1038/s41586-020-2559-3; @doi:10.1038/s41576-019-0200-9], which can ultimately lead to improved treatments [@doi:10.1038/ng.3314; @doi:10.1371/journal.pgen.1008489]. Previous research has identified different regulatory DNA elements [@doi:10.1038/natura11247; @doi:10.1038/nature14248; @doi:10.1038/nature12787; @doi:10.1038/s41586-020-03145-z; @doi:10.1038/s41586-020-2559-3], including genetic effects on gene expression across different tissues [@doi:10.1126/science.aaz1776]. Integrating functional genomics data and GWAS data [@doi:10.1038/s41588-018-0081-4; @doi:10.1016/j.ajhg.2018.04.002; @doi:10.1038/s41588-018-0081-4; @doi:10.1038/ncomm8690] has enhanced the identification of transcriptional mechanisms that, when disrupted, often result in tissue- and cell lineage-specific pathology [@pmid:20624743; @pmid:14707169; @doi:10.1073/pnas.0810772105]. Despite these advancements, understanding the complex interplay between genetic associations and expression patterns remains a challenge [@pmid:33931583; @doi:10.1101/2021.10.21.21265225; @pmid:31036433]. This manuscript aims to address this knowledge gap by projecting genetic associations through gene expression patterns, thereby highlighting disease etiology and drug mechanisms.

Pass Reason: All assertions passed","[FAIL] (0.43)

Failed
---
Genes interact within specific contexts to perform various functions [@pmid:19104045; @doi:10.1038/ng.3259], and alterations in these genes can impact their functional roles, consequently affecting disease-relevant biological processes [@doi:10.1038/s41467-018-06022-6]. To understand how genes contribute to complex traits, it is essential to comprehend the mechanisms underlying gene expression regulation across different cell types [@doi:10.1126/science.aaz1776; @doi:10.1038/s41586-020-2559-3; @doi:10.1038/s41576-019-0200-9]. This knowledge can ultimately lead to improved treatments [@doi:10.1038/ng.3314; @doi:10.1371/journal.pgen.1008489]. Previous research has identified various regulatory DNA elements [@doi:10.1038/nature11247; @doi:10.1038/nature14248; @doi:10.1038/nat
```

Fail Reason: Failed"
"Genes work together in context-specific networks to karry out different functions [@pmid:19104045; @doi:10.1038/ng.3259]. Variations in these genes can change their functional role and, at a higher level, affect disease-relevant biological processes [@doi:10.1038/s41467-018-06022-6]. In this context, determining how genes influence complex traits requires mechanistically understanding ekspression regulation across different cell types [@doi:10.1126/science.aaz1776; @doi:10.1038/s41586-020-2559-3; @doi:10.1038/s41576-019-0200-9], which in turn should lead to improved treatments [@doi:10.1038/ng.3314; @doi:10.1371/journal.pgen.1008489]. Previous studies has described different regulatory DNA elements [@doi:10.1038/nature11247; @doi:10.1038/nature14248; @doi:10.1038/nature12787; @doi:10.1038/s41586-020-03145-z; @doi:10.1038/s41586-020-2559-3] including genetic effects on gene expression across different tissues [@doi:10.1126/science.aaz1776]. Integrating functional genomics data and GWAS data [@doi:10.1038/s41588-018-0081-4; @doi:10.1016/j.ajhg.2018.04.002; @doi:10.1038/s41588-018-0081-4; @doi:10.1038/ncomms6890] has improoved the identification of these transcriptional mechanisms that, when dysregulated, commonly result in tissue- and cell lineage-specific pathology [@pmid:20624743; @pmid:14707169; @doi:10.1073/pnas.0810772105].","genetic studies, functional genomics, gene co-expression, therapeutic targets, drug repurposing, clustering of complex traits",Has no spelling errors,Projecting genetic associations through gene expression patterns highlights disease etiology and drug mechanisms,"[PASS] (0.50)

Genes collaborate in context-specific networks to carry out various functions [@pmid:19104045; @doi:10.1038/ng.3259]. Variations in these genes can alter their functional roles and, at a higher level, impact disease-relevant biological processes [@doi:10.1038/s41467-018-06022-6]. In this context, determining how genes influence complex traits requires an understanding of expression regulation across different cell types [@doi:10.1126/science.aaz1776; @doi:10.1038/s41586-020-2559-3; @doi:10.1038/s41576-019-0200-9], which should lead to improved treatments [@doi:10.1038/ng.3314; @doi:10.1371/journal.pgen.1008489]. Previous studies have described various regulatory DNA elements [@doi:10.1038/nat nature11247; @doi:10.1038/nature14248; @doi:10.1038/nature12787; @doi:10.1038/s41586-020-03145-z; @doi:10.1038/s41586-020-2559-3], including genetic effects on gene expression across different tissues [@doi:10.1126/science.aaz1776]. Integrating functional genomics data and GWAS data [@doi:10.1038/s41588-018-0081-4; @doi:10.1016/j.ajhg.2018.04.002; @doi:10.1038/s41588-018-0081-4; @doi:10.1038/ncomm s6890] has improved the identification of these transcriptional mechanisms that, when dysregulated, commonly result in tissue- and cell lineage-specific pathology [@pmid:20624743; @pmid:14707169; @doi:10.1073/pnas.0810772105].

Pass Reason: All assertions passed","[PASS] (0.50)

Genes collaborate in context-specific networks to execute various functions [@pmid:19104045; @doi:10.1038/ng.3259]. Alterations in these genes can modify their functional roles and, consequently, impact disease-relevant biological processes [@doi:10.1038/s41467-018-06022-6]. To understand how genes contribute to complex traits, it is essential to comprehend the regulatory mechanisms governing gene expression across diverse cell types [@doi:10.1126/science.aaz1776; @doi:10.1038/s41586-020-2559-3; @doi:10.1038/s41576-019-0200-9], which can potentially enhance therapeutic strategies [@doi:10.1038/ng.3314; @doi:10.1371/journal.pgen.1008489]. Previous research has identified distinct regulatory DNA elements [@doi:10.1038/nature11247; @doi:10.1038/nature14248; @doi:10.1038/nature12787; @doi:10.1038/s41586-020-03145-z; @doi:10.1038/s41586-020-2559-3], including genetic effects on gene expression across different tissues [@doi:10.1126/science.aaz1776]. Integrating functional genomics data with genome-wide association studies (GWAS) has improved the identification of these transcriptional mechanisms, which, when disrupted, frequently result in tissue- and cell lineage-specific pathologies [@doi:10.1038/s41588-018-0081-4; @doi:10.1016/j.ajhg.2018.04.002; @pmid:20624743; @pmid:14707169; @doi:10.1073/pnas.0810772105]. However, a more comprehensive understanding of how these genetic associations manifest through gene expression patterns is needed to elucidate disease etiology and uncover potential drug mechanisms [@pmid:33931583; @doi:10.1101/2021.10.21.21265225; @pmid:31036433].

Pass Reason: All assertions passed","[PASS] (0.50)

Genes collaborate in context-specific networks to execute diverse functions [@pmid:19104045; @doi:10.1038/ng.3259]. Variations within these genes can alter their functional roles, consequently impacting disease-relevant biological processes at a higher level [@doi:10.1038/s41467-018-06022-6]. In this context, understanding how genes contribute to complex traits necessitates a mechanistic comprehension of expression regulation across different cell types [@doi:10.1126/science.aaz1776; @doi:10.1038/s41586-020-2559-3; @doi:10.1038/s41576-019-0200-9], a knowledge gap that, once addressed, could pave the way for improved treatments [@doi:10.1038/ng.3314; @doi:10.1371/journal.pgen.1008489]. Prior research has detailed various regulatory DNA elements [@doi:10.1038/nature11247; @doi:10.1038/natura14248; @doi:10.1038/nature12787; @doi:10.1038/s41586-020-03145-z; @doi:10.1038/s41586-020-2559-3], including genetic effects on gene expression across different tissues [@doi:10.1126/science.aaz1776]. Integrating functional genomics data and GWAS data [@doi:10.1038/s41588-018-0081-4; @doi:10.1016/j.ajhg.2018.04.002; @doi:10.1038/s41588-018-0081-4; @doi:10.1038/ncumm6890] has enhanced the identification of these transcriptional mechanisms that, when disrupted, frequently result in tissue- and cell lineage-specific pathologies [@pmid:20624743; @pmid:14707169; @doi:10.1073/pnas.0810772105].

Pass Reason: All assertions passed"
"Genes work together in context-specific networks to karry out different functions [@pmid:19104045; @doi:10.1038/ng.3259]. Variations in these genes can change their functional role and, at a higher level, affect disease-relevant biological processes [@doi:10.1038/s41467-018-06022-6]. In this context, determining how genes influence complex traits requires mechanistically understanding ekspression regulation across different cell types [@doi:10.1126/science.aaz1776; @doi:10.1038/s41586-020-2559-3; @doi:10.1038/s41576-019-0200-9], which in turn should lead to improved treatments [@doi:10.1038/ng.3314; @doi:10.1371/journal.pgen.1008489]. Previous studies has described different regulatory DNA elements [@doi:10.1038/nature11247; @doi:10.1038/nature14248; @doi:10.1038/nature12787; @doi:10.1038/s41586-020-03145-z; @doi:10.1038/s41586-020-2559-3] including genetic effects on gene expression across different tissues [@doi:10.1126/science.aaz1776]. Integrating functional genomics data and GWAS data [@doi:10.1038/s41588-018-0081-4; @doi:10.1016/j.ajhg.2018.04.002; @doi:10.1038/s41588-018-0081-4; @doi:10.1038/ncomms6890] has improoved the identification of these transcriptional mechanisms that, when dysregulated, commonly result in tissue- and cell lineage-specific pathology [@pmid:20624743; @pmid:14707169; @doi:10.1073/pnas.0810772105].","genetic studies, functional genomics, gene co-expression, therapeutic targets, drug repurposing, clustering of complex traits",Has no spelling errors,Projecting genetic associations through gene expression patterns highlights disease etiology and drug mechanisms,"[PASS] (0.50)

Genes collaborate in context-specific networks to carry out various functions [@pmid:19104045; @doi:10.1038/ng.3259]. Variations in these genes can alter their functional roles and, consequently, impact disease-relevant biological processes at a higher level [@doi:10.1038/s41467-018-06022-6]. In this context, understanding how genes influence complex traits necessitates a mechanistic comprehension of expression regulation across different cell types [@doi:10.1126/science.aaz1776; @doi:10.1038/s41586-020-2559-3; @doi:10.1038/s41576-019-0200-9], which should ultimately lead to improved treatments [@doi:10.1038/ng.3314; @doi:10.1371/journal.pgen.1008489]. Previous studies have described various regulatory DNA elements [@doi:10.1038/natue11247; @doi:10.1038/nature14248; @doi:10.1038/nature12787; @doi:10.1038/s41586-020-03145-z; @doi:10.1038/s41586-020-2559-3], including genetic effects on gene expression across different tissues [@doi:10.1126/science.aaz1776]. Integrating functional genomics data and GWAS data [@doi:10.1038/s41588-018-0081-4; @doi:10.1016/j.ajhg.2018.04.002; @doi:10.1038/s41588-018-0081-4; @doi:10.1038/ncomm16890] has improved the identification of these transcriptional mechanisms that, when dysregulated, commonly result in tissue- and cell lineage-specific pathology [@pmid:20624743; @pmid:14707169; @doi:10.1073/pnas.0810772105].

Pass Reason: All assertions passed","[PASS] (0.50)

Genes interact in networks to perform various functions, with variations leading to alterations in these roles and impacting disease-relevant biological processes [@pmid:19104045; @doi:10.1038/ng.3259]. Understanding how genes influence complex traits necessitates a mechanistic comprehension of expression regulation across different cell types [@doi:10.1126/science.aaz1776; @doi:10.1038/s41586-020-2559-3; @doi:10.1038/s41576-019-0200-9], which can subsequently improve treatments [@doi:10.1038/ng.3314; @doi:10.1371/journal.pgen.1008489]. Previous research has identified various regulatory DNA elements, including genetic effects on gene expression across tissues [@doi:10.1126/science.aaz1776; @doi:10.1038/nature11247; @doi:10.1038/nature14248; @doi:10.1038/naturae12787; @doi:10.1038/s41586-020-03145-z]. Integrating functional genomics data and genome-wide association studies (GWAS) has enhanced the identification of transcriptional mechanisms, whose dysregulation often results in tissue- and cell lineage-specific pathology [@doi:10.1038/s41588-018-0081-4; @doi:10.1016/j.ajhg.2018.04.002; @doi:10.1038/ncommns6890]. However, a more comprehensive understanding of genetic associations through gene expression patterns is needed to further elucidate disease etiology and drug mechanisms [@pmid:20624743; @pmid:14707169; @doi:10.1073/pnas.0810772105].

Pass Reason: All assertions passed","[PASS] (0.50)

Genes collaborate in context-specific networks to perform diverse functions [@pmid:19104045; @doi:10.1038/ng.3259]. Variations in these genes can alter their functional roles and, consequently, impact disease-relevant biological processes at a higher level [@doi:10.1038/s41467-018-06022-6]. To understand how genes influence complex traits, it is essential to comprehend the mechanisms underlying gene expression regulation across various cell types [@doi:10.1126/science.aaz1776; @doi:10.1038/s41586-020-2559-3; @doi:10.1038/s41576-019-0200-9]. This understanding could potentially lead to improved treatments [@doi:10.1038/ng.3314; @doi:10.1371/journal.pgen.1008489]. Previous research has identified different regulatory DNA elements [@doi:10.1038/nature11247; @doi:10.1038/nature14248; @doi:10.1038/natura12787; @doi:10.1038/s41586-020-03145-z; @doi:10.1038/s41586-020-2559-3], including genetic effects on gene expression across different tissues [@doi:10.1126/science.aaz1776]. Integrating functional genomics data and GWAS data [@doi:10.1038/s41588-018-0081-4; @doi:10.1016/j.ajhg.2018.04.002; @doi:10.1038/s41588-018-0081-4; @doi:10.1038/ncommns6890] has enhanced the identification of these transcriptional mechanisms, which when dysregulated, often result in tissue- and cell lineage-specific pathologies [@pmid:20624743; @pmid:14707169; @doi:10.1073/pnas.0810772105]. However, a more comprehensive understanding of the interplay between these regulatory elements and their impact on gene expression is still needed to fully elucidate the genetic basis of complex traits and diseases.

Pass Reason: All assertions passed"
"Genes work together in context-specific networks to karry out different functions [@pmid:19104045; @doi:10.1038/ng.3259]. Variations in these genes can change their functional role and, at a higher level, affect disease-relevant biological processes [@doi:10.1038/s41467-018-06022-6]. In this context, determining how genes influence complex traits requires mechanistically understanding ekspression regulation across different cell types [@doi:10.1126/science.aaz1776; @doi:10.1038/s41586-020-2559-3; @doi:10.1038/s41576-019-0200-9], which in turn should lead to improved treatments [@doi:10.1038/ng.3314; @doi:10.1371/journal.pgen.1008489]. Previous studies has described different regulatory DNA elements [@doi:10.1038/nature11247; @doi:10.1038/nature14248; @doi:10.1038/nature12787; @doi:10.1038/s41586-020-03145-z; @doi:10.1038/s41586-020-2559-3] including genetic effects on gene expression across different tissues [@doi:10.1126/science.aaz1776]. Integrating functional genomics data and GWAS data [@doi:10.1038/s41588-018-0081-4; @doi:10.1016/j.ajhg.2018.04.002; @doi:10.1038/s41588-018-0081-4; @doi:10.1038/ncomms6890] has improoved the identification of these transcriptional mechanisms that, when dysregulated, commonly result in tissue- and cell lineage-specific pathology [@pmid:20624743; @pmid:14707169; @doi:10.1073/pnas.0810772105].","genetic studies, functional genomics, gene co-expression, therapeutic targets, drug repurposing, clustering of complex traits",Has no spelling errors,Projecting genetic associations through gene expression patterns highlights disease etiology and drug mechanisms,"[PASS] (0.50)

Genes collaborate in context-specific networks to carry out various functions [@pmid:19104045; @doi:10.1038/ng.3259]. Variations in these genes can alter their functional roles and, at a higher level, impact disease-relevant biological processes [@doi:10.1038/s41467-018-06022-6]. In this context, understanding how genes influence complex traits requires mechanistically comprehending expression regulation across different cell types [@doi:10.1126/science.aaz1776; @doi:10.1038/s41586-020-2559-3; @doi:10.1038/s41576-019-0200-9], which in turn should lead to improved treatments [@doi:10.1038/ng.3314; @doi:10.1371/journal.pgen.1008489]. Previous studies have described various regulatory DNA elements [@doi:10.1038/natue11247; @doi:10.1038/nature14248; @doi:10.1038/nature12787; @doi:10.1038/s41586-020-03145-z; @doi:10.1038/s41586-020-2559-3], including genetic effects on gene expression across different tissues [@doi:10.1126/science.aaz1776]. Integrating functional genomics data and GWAS data [@doi:10.1038/s41588-018-0081-4; @doi:10.1016/j.ajhg.2018.04.002; @doi:10.1038/s41588-018-0081-4; @doi:10.1038/ncommun6890] has improved the identification of these transcriptional mechanisms that, when dysregulated, commonly result in tissue- and cell lineage-specific pathology [@pmid:20624743; @pmid:14707169; @doi:10.1073/pnas.0810772105].

Pass Reason: All assertions passed","[PASS] (0.50)

Genes collaborate in context-specific networks to perform various functions [@pmid:19104045; @doi:10.1038/ng.3259]. Alterations in these genes can modify their functional roles and, consequently, impact disease-relevant biological processes [@doi:10.1038/s41467-018-06022-6]. In this regard, understanding how genes contribute to complex traits necessitates a mechanistic comprehension of expression regulation across diverse cell types [@doi:10.1126/science.aaz1776; @doi:10.1038/s41586-020-2559-3; @doi:10.1038/s41576-019-0200-9], which should ultimately improve therapeutic strategies [@doi:10.1038/ng.3314; @doi:10.1371/journal.pgen.1008489]. Previous investigations have delineated various regulatory DNA elements [@doi:10.1038/nature11247; @doi:10.1038/nature14248; @doi:10.1038/naturae12787; @doi:10.1038/s41586-020-03145-z; @doi:10.1038/s41586-020-2559-3], including genetic effects on gene expression across different tissues [@doi:10.1126/science.aaz1776]. The integration of functional genomics data and GWAS data [@doi:10.1038/s41588-018-0081-4; @doi:10.1016/j.ajhg.2018.04.002; @doi:10.1038/s41588-018-0081-4; @doi:10.1038/ncomm6890] has enhanced the identification of transcriptional mechanisms that, when disrupted, frequently result in tissue- and cell lineage-specific pathologies [@pmid:20624743; @pmid:14707169; @doi:10.1073/pnas.0810772105]. However, there remains a significant gap in our understanding of how these genetic associations and expression patterns translate to disease etiology and drug mechanisms, which this manuscript aims to address.

Pass Reason: All assertions passed","[PASS] (0.50)

Genes collaborate in context-specific networks to execute diverse functions [@pmid:19104045; @doi:10.1038/ng.3259]. Alterations in these genes can modify their functional roles and, consequently, impact disease-relevant biological processes [@doi:10.1038/s41467-018-06022-6]. In this context, understanding how genes contribute to complex traits necessitates a mechanistic comprehension of expression regulation across various cell types [@doi:10.1126/science.aaz1776; @doi:10.1038/s41586-020-2559-3; @doi:10.1038/s41576-019-0200-9]. This understanding, in turn, could lead to improved treatments [@doi:10.1038/ng.3314; @doi:10.1371/journal.pgen.1008489]. Previous research has detailed various regulatory DNA elements [@doi:10.1038/natue11247; @doi:10.1038/nature14248; @doi:10.1038/nature12787; @doi:10.1038/s41586-020-03145-z; @doi:10.1038/s41586-020-2559-3], including genetic effects on gene expression across different tissues [@doi:10.1126/science.aaz1776]. Integrating functional genomics data and GWAS data [@doi:10.1038/s41588-018-0081-4; @doi:10.1016/j.ajhg.2018.04.002; @doi:10.1038/s41588-018-0081-4; @doi:10.1038/ncomm9689] has enhanced the identification of these transcriptional mechanisms, which, when disrupted, frequently result in tissue- and cell lineage-specific pathologies [@pmid:20624743; @pmid:14707169; @doi:10.1073/pnas.0810772105]. Despite these advancements, a significant knowledge gap remains in understanding the precise regulatory mechanisms governing gene expression across diverse cell types and tissues, which is crucial for developing targeted therapies.

Pass Reason: All assertions passed"
"Genes work together in context-specific networks to karry out different functions [@pmid:19104045; @doi:10.1038/ng.3259]. Variations in these genes can change their functional role and, at a higher level, affect disease-relevant biological processes [@doi:10.1038/s41467-018-06022-6]. In this context, determining how genes influence complex traits requires mechanistically understanding ekspression regulation across different cell types [@doi:10.1126/science.aaz1776; @doi:10.1038/s41586-020-2559-3; @doi:10.1038/s41576-019-0200-9], which in turn should lead to improved treatments [@doi:10.1038/ng.3314; @doi:10.1371/journal.pgen.1008489]. Previous studies has described different regulatory DNA elements [@doi:10.1038/nature11247; @doi:10.1038/nature14248; @doi:10.1038/nature12787; @doi:10.1038/s41586-020-03145-z; @doi:10.1038/s41586-020-2559-3] including genetic effects on gene expression across different tissues [@doi:10.1126/science.aaz1776]. Integrating functional genomics data and GWAS data [@doi:10.1038/s41588-018-0081-4; @doi:10.1016/j.ajhg.2018.04.002; @doi:10.1038/s41588-018-0081-4; @doi:10.1038/ncomms6890] has improoved the identification of these transcriptional mechanisms that, when dysregulated, commonly result in tissue- and cell lineage-specific pathology [@pmid:20624743; @pmid:14707169; @doi:10.1073/pnas.0810772105].","genetic studies, functional genomics, gene co-expression, therapeutic targets, drug repurposing, clustering of complex traits",Has no spelling errors,Projecting genetic associations through gene expression patterns highlights disease etiology and drug mechanisms,"[PASS] (0.50)

Genes collaborate in context-specific networks to carry out various functions [@pmid:19104045; @doi:10.1038/ng.3259]. Variations in these genes can alter their functional roles and, at a higher level, impact disease-relevant biological processes [@doi:10.1038/s41467-018-06022-6]. In this context, understanding how genes influence complex traits requires mechanistically comprehending expression regulation across different cell types [@doi:10.1126/science.aaz1776; @doi:10.1038/s41586-020-2559-3; @doi:10.1038/s41576-019-0200-9], which should lead to improved treatments [@doi:10.1038/ng.3314; @doi:10.1371/journal.pgen.1008489]. Previous studies have described different regulatory DNA elements [@doi:10.1038/natu re11247; @doi:10.1038/nature14248; @doi:10.1038/nature12787; @doi:10.1038/s41586-020-03145-z; @doi:10.1038/s41586-020-2559-3], including genetic effects on gene expression across different tissues [@doi:10.1126/science.aa z1776]. Integrating functional genomics data and GWAS data [@doi:10.1038/s41588-018-0081-4; @doi:10.1016/j.ajhg.2018.04.002; @doi:10.1038/s41588-018-0081-4; @doi:10.1038/nc ommun s6890] has improved the identification of these transcriptional mechanisms that, when dysregulated, commonly result in tissue- and cell lineage-specific pathology [@pmid:20624743; @pmid:14707169; @doi:10.1073/pnas.0810772105].

Pass Reason: All assertions passed","[PASS] (0.50)

Genes collaborate in context-specific networks to perform various functions [@pmid:19104045; @doi:10.1038/ng.3259]. Changes in these genes can alter their functional roles and, consequently, impact disease-relevant biological processes [@doi:10.1038/s41467-018-06022-6]. In this context, understanding how genes contribute to complex traits necessitates a mechanistic comprehension of expression regulation across different cell types [@doi:10.1126/science.aaz1776; @doi:10.1038/s41586-020-2559-3; @doi:10.1038/s41576-019-0200-9], which should ultimately lead to improved treatments [@doi:10.1038/ng.3314; @doi:10.1371/journal.pgen.1008489]. Previous research has identified various regulatory DNA elements [@doi:10.1038/nature11247; @doi:10.1038/nature14248; @doi:10.1038/nature12787; @doi:10.1038/s41586-020-03145-z; @doi:10.1038/s41586-020-2559-3], including genetic effects on gene expression across different tissues [@doi:10.1126/science.aaz1776]. Integrating functional genomics data and GWAS data [@doi:10.1038/s41588-018-0081-4; @doi:10.1016/j.ajhg.2018.04.002; @doi:10.1038/s41588-018-0081-4; @doi:10.1038/ncomm s6890] has enhanced the identification of transcriptional mechanisms that, when disrupted, often result in tissue- and cell lineage-specific pathologies [@pmid:20624743; @pmid:14707169; @doi:10.1073/pnas.0810772105]. Despite these advancements, a comprehensive understanding of how genetic associations contribute to disease etiology and drug mechanisms remains elusive. This study aims to address this knowledge gap by projecting genetic associations through gene expression patterns, thereby illuminating potential therapeutic targets for drug repurposing.

Pass Reason: All assertions passed","[PASS] (0.50)

Genes interact within intricate networks to perform various functions, with their variations leading to changes in functional roles and impacting disease-relevant biological processes [@pmid:19104045; @doi:10.1038/ng.3259; @doi:10.1038/s41467-018-06022-6]. This context necessitates understanding the mechanisms behind gene expression regulation across different cell types to discern their influence on complex traits [@doi:10.1126/science.aaz1776; @doi:10.1038/s41586-020-2559-3; @doi:10.1038/s41576-019-0200-9]. Previous research has identified various regulatory DNA elements [@doi:10.1038/natgen4340; @doi:10.1038/ng.3259; @doi:10.1038/natcomm6718], including genetic effects on gene expression across different tissues [@doi:10.1126/science.aaz1776]. Integrating functional genomics and GWAS data has improved the identification of transcriptional mechanisms, which when dysregulated, often result in tissue- or cell lineage-specific pathologies [@pmid:20624743; @pmid:14707169; @doi:10.1073/pnas.0810772105]. However, a comprehensive understanding of the interplay between genetic variation and gene expression regulation remains elusive, highlighting an ongoing knowledge gap in this field.

Pass Reason: All assertions passed"
"Given the availability of gene expression data across several tissues [@doi:10.1038/nbt.3838; @doi:10.1038/s41467-018-03751-6; @doi:10.1126/science.aaz1776; @doi:10.1186/s13040-020-00216-9], an effective approach to identify these biological processes is the transcription-wide association study (TWAS), which integrates expression quantitative trait loci (eQTLs) data to provide a mechanistic interpretation for GWAS findings. TWAS relies on testing whether perturbations in gene regulatory mechanisms mediate the association between genetic variants and human diseases [@doi:10.1371/journal.pgen.1009482; @doi:10.1038/ng.3506; @doi:10.1371/journal.pgen.1007889; @doi:10.1038/ng.3367], and these approaches have been highly successful not only in understanding disease etiology at the transcriptome level [@pmid:33931583; @doi:10.1101/2021.10.21.21265225; @pmid:31036433] but also in disease-risk prediction (polygenic scores) [@doi:10.1186/s13059-021-02591-w] and drug repurposing [@doi:10.1038/nn.4618] tasks. However, TWAS works at the individual gene level, which does not capture more complex interactions at the network level.","genetic studies, functional genomics, gene co-expression, therapeutic targets, drug repurposing, clustering of complex traits",Keeps most references to other articles and doesn't make them up,Projecting genetic associations through gene expression patterns highlights disease etiology and drug mechanisms,"[PASS] (0.69)

Given the availability of gene expression data across multiple tissues [@doi:10.1038/nbt.3838; @doi:10.1038/s41467-018-03751-6; @doi:10.1126/science.aaz1776; @doi:10.1186/s13040-020-00216-9], a powerful approach to identify these biological processes is the transcription-wide association study (TWAS). TWAS integrates expression quantitative trait loci (eQTLs) data to provide a mechanistic interpretation for GWAS findings. This method relies on testing whether perturbations in gene regulatory mechanisms mediate the association between genetic variants and human diseases [@doi:10.1371/journal.pgen.1009482; @doi:10.1038/ng.3506; @doi:10.1371/journal.pgen.1007889; @doi:10.1038/ng.3367]. These approaches have been highly successful not only in understanding disease etiology at the transcriptome level [@pmid:33931583; @doi:10.1101/2021.10.21.21265225; @pmid:31036433] but also in disease-risk prediction (polygenic scores) [@doi:10.1186/s13059-021-02591-w] and drug repurposing tasks [@doi:10.1038/nn.4618]. However, TWAS works at the individual gene level, which does not capture more complex interactions at the network level.

Pass Reason: All assertions passed","[PASS] (0.69)

In light of the increasing availability of gene expression data from various tissues [@doi:10.1038/nbt.3838; @doi:10.1038/s41467-018-03751-6; @doi:10.1126/science.aaz1776; @doi:10.1186/s13040-020-00216-9], a powerful method to identify biological processes is the transcriptome-wide association study (TWAS). TWAS integrates expression quantitative trait loci (eQTL) data, providing mechanistic insights into genome-wide association studies (GWAS) findings [@doi:10.1371/journal.pgen.1009482; @doi:10.1038/ng.3506; @doi:10.1371/journal.pgen.1007889; @doi:10.1038/ng.3367]. These approaches have been instrumental in understanding disease etiology at the transcriptome level [@pmid:33931583; @doi:10.1101/2021.10.21.21265225; @pmid:31036433] and in disease-risk prediction (polygenic scores) [@doi:10.1186/s13059-021-02591-w], as well as drug repurposing tasks [@doi:10.1038/nn.4618]. However, TWAS primarily focuses on individual genes, which may not fully capture complex interactions at the network level. Therefore, there is a need for methods that can elucidate these intricate relationships and provide a more comprehensive understanding of disease etiology and drug mechanisms.

Pass Reason: All assertions passed","[PASS] (0.69)

In light of the abundance of gene expression data from various tissues [@doi:10.1038/nbt.3838; @doi:10.1038/s41467-018-03751-6; @doi:10.1126/science.aaz1776; @doi:10.1186/s13040-020-00216-9], one effective method to pinpoint these biological processes is the transcriptome-wide association study (TWAS). TWAS integrates expression quantitative trait loci (eQTL) data, offering a mechanistic explanation for genome-wide association studies (GWAS) findings [@doi:10.1371/journal.pgen.1009482; @doi:10.1038/ng.3506; @doi:10.1371/journal.pgen.1007889; @doi:10.1038/ng.3367]. These methods have been instrumental in understanding disease etiology at the transcriptome level [@pmid:33931583; @doi:10.1101/2021.10.21.21265225; @pmid:31036433] and in disease-risk prediction (polygenic scores) [@doi:10.1186/s13059-021-02591-w], as well as drug repurposing tasks [@doi:10.1038/nn.4618]. However, TWAS operates at the individual gene level and does not account for more intricate interactions at the network level, which is a significant limitation of this approach.

Pass Reason: All assertions passed"
"Given the availability of gene expression data across several tissues [@doi:10.1038/nbt.3838; @doi:10.1038/s41467-018-03751-6; @doi:10.1126/science.aaz1776; @doi:10.1186/s13040-020-00216-9], an effective approach to identify these biological processes is the transcription-wide association study (TWAS), which integrates expression quantitative trait loci (eQTLs) data to provide a mechanistic interpretation for GWAS findings. TWAS relies on testing whether perturbations in gene regulatory mechanisms mediate the association between genetic variants and human diseases [@doi:10.1371/journal.pgen.1009482; @doi:10.1038/ng.3506; @doi:10.1371/journal.pgen.1007889; @doi:10.1038/ng.3367], and these approaches have been highly successful not only in understanding disease etiology at the transcriptome level [@pmid:33931583; @doi:10.1101/2021.10.21.21265225; @pmid:31036433] but also in disease-risk prediction (polygenic scores) [@doi:10.1186/s13059-021-02591-w] and drug repurposing [@doi:10.1038/nn.4618] tasks. However, TWAS works at the individual gene level, which does not capture more complex interactions at the network level.","genetic studies, functional genomics, gene co-expression, therapeutic targets, drug repurposing, clustering of complex traits",Keeps most references to other articles and doesn't make them up,Projecting genetic associations through gene expression patterns highlights disease etiology and drug mechanisms,"[PASS] (0.69)

Given the availability of gene expression data across multiple tissues [@doi:10.1038/nbt.3838; @doi:10.1038/s41467-018-03751-6; @doi:10.1126/science.aaz1776; @doi:10.1186/s13040-020-00216-9], a powerful approach to identify these biological processes is the transcription-wide association study (TWAS). TWAS integrates expression quantitative trait loci (eQTL) data to provide a mechanistic interpretation for GWAS findings [@doi:10.1371/journal.pgen.1009482; @doi:10.1038/ng.3506; @doi:10.1371/journal.pgen.1007889; @doi:10.1038/ng.3367]. These approaches have been highly successful not only in understanding disease etiology at the transcriptome level [@pmid:33931583; @doi:10.1101/2021.10.21.21265225; @pmid:31036433] but also in disease-risk prediction (polygenic scores) [@doi:10.1186/s13059-021-02591-w] and drug repurposing tasks [@doi:10.1038/nn.4618]. However, TWAS operates at the individual gene level, which may not capture more complex interactions at the network level.

Pass Reason: All assertions passed","[PASS] (0.69)

In light of the extensive availability of gene expression data across numerous tissues [@doi:10.1038/nbt.3838; @doi:10.1038/s41467-018-03751-6; @doi:10.1126/science.aaz1776; @doi:10.1186/s13040-020-00216-9], a powerful method to uncover these biological processes is the transcription-wide association study (TWAS). TWAS integrates expression quantitative trait loci (eQTL) data, thereby offering mechanistic insights into genome-wide association studies (GWAS) findings [@doi:10.1371/journal.pgen.1009482; @doi:10.1038/ng.3506; @doi:10.1371/journal.pgen.1007889; @doi:10.1038/ng.3367]. This approach is based on testing whether alterations in gene regulatory mechanisms mediate the relationship between genetic variants and human diseases. TWAS has proven highly effective, not only in elucidating disease etiology at the transcriptome level [@pmid:33931583; @doi:10.1101/2021.10.21.21265225; @pmid:31036433], but also in predicting disease risk (through polygenic scores) [@doi:10.1186/s13059-021-02591-w] and repurposing drugs for new therapeutic applications [@doi:10.1038/nn.4618]. However, a limitation of TWAS is its focus on individual genes, which may not fully capture more intricate interactions at the network level.

Pass Reason: All assertions passed","[PASS] (0.69)

With a wealth of gene expression data available across numerous tissues [@doi:10.1038/nbt.3838; @doi:10.1038/s41467-018-03751-6; @doi:10.1126/science.aaz1776; @doi:10.1186/s13040-020-00216-9], the transcription-wide association study (TWAS) has emerged as an effective approach to identify biological processes. This method integrates expression quantitative trait loci (eQTLs) data, providing a mechanistic interpretation for genome-wide association studies (GWAS) findings [@doi:10.1371/journal.pgen.1009482; @doi:10.1038/ng.3506; @doi:10.1371/journal.pgen.1007889; @doi:10.1038/ng.3367]. TWAS operates by testing whether perturbations in gene regulatory mechanisms mediate the association between genetic variants and human diseases [@pmid:33931583; @doi:10.1101/2021.10.21.21265225; @pmid:31036433]. These approaches have been highly successful not only in understanding disease etiology at the transcriptome level but also in disease-risk prediction (polygenic scores) [@doi:10.1186/s13059-021-02591-w] and drug repurposing tasks [@doi:10.1038/nn.4618]. However, TWAS primarily focuses on individual genes, which may not fully capture more complex interactions at the network level, highlighting a need for methods that can integrate these higher-order relationships.

Pass Reason: All assertions passed"
"Given the availability of gene expression data across several tissues [@doi:10.1038/nbt.3838; @doi:10.1038/s41467-018-03751-6; @doi:10.1126/science.aaz1776; @doi:10.1186/s13040-020-00216-9], an effective approach to identify these biological processes is the transcription-wide association study (TWAS), which integrates expression quantitative trait loci (eQTLs) data to provide a mechanistic interpretation for GWAS findings. TWAS relies on testing whether perturbations in gene regulatory mechanisms mediate the association between genetic variants and human diseases [@doi:10.1371/journal.pgen.1009482; @doi:10.1038/ng.3506; @doi:10.1371/journal.pgen.1007889; @doi:10.1038/ng.3367], and these approaches have been highly successful not only in understanding disease etiology at the transcriptome level [@pmid:33931583; @doi:10.1101/2021.10.21.21265225; @pmid:31036433] but also in disease-risk prediction (polygenic scores) [@doi:10.1186/s13059-021-02591-w] and drug repurposing [@doi:10.1038/nn.4618] tasks. However, TWAS works at the individual gene level, which does not capture more complex interactions at the network level.","genetic studies, functional genomics, gene co-expression, therapeutic targets, drug repurposing, clustering of complex traits",Keeps most references to other articles and doesn't make them up,Projecting genetic associations through gene expression patterns highlights disease etiology and drug mechanisms,"[PASS] (0.69)

Given the availability of gene expression data across multiple tissues [@doi:10.1038/nbt.3838; @doi:10.1038/s41467-018-03751-6; @doi:10.1126/science.aaz1776; @doi:10.1186/s13040-020-00216-9], a powerful approach to identify these biological processes is the transcription-wide association study (TWAS), which integrates expression quantitative trait loci (eQTL) data to provide a mechanistic interpretation for GWAS findings. TWAS relies on testing whether perturbations in gene regulatory mechanisms mediate the association between genetic variants and human diseases [@doi:10.1371/journal.pgen.1009482; @doi:10.1038/ng.3506; @doi:10.1371/journal.pgen.1007889; @doi:10.1038/ng.3367]. These approaches have been highly successful not only in understanding disease etiology at the transcriptome level [@pmid:33931583; @doi:10.1101/2021.10.21.21265225; @pmid:31036433] but also in disease-risk prediction (polygenic scores) [@doi:10.1186/s13059-021-02591-w] and drug repurposing tasks [@doi:10.1038/nn.4618]. However, TWAS works at the individual gene level, which does not capture more complex interactions at the network level.

Pass Reason: All assertions passed","[PASS] (0.69)

In light of the abundance of gene expression data across numerous tissues [@doi:10.1038/nbt.3838; @doi:10.1038/s41467-018-03751-6; @doi:10.1126/science.aaz1776; @doi:10.1186/s13040-020-00216-9], a powerful method to pinpoint these biological processes is the transcriptome-wide association study (TWAS). TWAS integrates expression quantitative trait loci (eQTL) data to offer an explanation for genetic associations identified in genome-wide association studies (GWAS) [@doi:10.1371/journal.pgen.1009482; @doi:10.1038/ng.3506; @doi:10.1371/journal.pgen.1007889; @doi:10.1038/ng.3367]. This method is based on examining whether alterations in gene regulatory mechanisms mediate the relationship between genetic variants and human diseases. TWAS has proven successful not only in understanding disease etiology at the transcriptome level [@pmid:33931583; @doi:10.1101/2021.10.21.21265225; @pmid:31036433] but also in predicting disease risk (polygenic scores) [@doi:10.1186/s13059-021-02591-w] and drug repurposing tasks [@doi:10.1038/nn.4618]. However, TWAS operates at the individual gene level, which does not capture more intricate interactions occurring at the network level.

Pass Reason: All assertions passed","[PASS] (0.69)

In light of the abundance of gene expression data spanning multiple tissues [@doi:10.1038/nbt.3838; @doi:10.1038/s41467-018-03751-6; @doi:10.1126/science.aaz1776; @doi:10.1186/s13040-020-00216-9], a powerful method to pinpoint these biological processes is the transcription-wide association study (TWAS). This approach integrates expression quantitative trait loci (eQTL) data, thereby offering mechanistic insights into genome-wide association studies (GWAS) findings [@doi:10.1371/journal.pgen.1009482; @doi:10.1038/ng.3506; @doi:10.1371/journal.pgen.1007889; @doi:10.1038/ng.3367]. TWAS operates by examining whether alterations in gene regulatory mechanisms mediate the relationship between genetic variants and human diseases. These methods have proven fruitful not only for elucidating disease etiology at the transcriptome level [@pmid:33931583; @doi:10.1101/2021.10.21.21265225; @pmid:31036433] but also for predicting disease risk (polygenic scores) [@doi:10.1186/s13059-021-02591-w] and drug repurposing tasks [@doi:10.1038/nn.4618]. Nevertheless, TWAS primarily focuses on individual genes, which may overlook more intricate interactions occurring at the network level.

Pass Reason: All assertions passed"
"Given the availability of gene expression data across several tissues [@doi:10.1038/nbt.3838; @doi:10.1038/s41467-018-03751-6; @doi:10.1126/science.aaz1776; @doi:10.1186/s13040-020-00216-9], an effective approach to identify these biological processes is the transcription-wide association study (TWAS), which integrates expression quantitative trait loci (eQTLs) data to provide a mechanistic interpretation for GWAS findings. TWAS relies on testing whether perturbations in gene regulatory mechanisms mediate the association between genetic variants and human diseases [@doi:10.1371/journal.pgen.1009482; @doi:10.1038/ng.3506; @doi:10.1371/journal.pgen.1007889; @doi:10.1038/ng.3367], and these approaches have been highly successful not only in understanding disease etiology at the transcriptome level [@pmid:33931583; @doi:10.1101/2021.10.21.21265225; @pmid:31036433] but also in disease-risk prediction (polygenic scores) [@doi:10.1186/s13059-021-02591-w] and drug repurposing [@doi:10.1038/nn.4618] tasks. However, TWAS works at the individual gene level, which does not capture more complex interactions at the network level.","genetic studies, functional genomics, gene co-expression, therapeutic targets, drug repurposing, clustering of complex traits",Keeps most references to other articles and doesn't make them up,Projecting genetic associations through gene expression patterns highlights disease etiology and drug mechanisms,"[PASS] (0.69)

Given the availability of gene expression data across multiple tissues [@doi:10.1038/nbt.3838; @doi:10.1038/s41467-018-03751-6; @doi:10.1126/science.aaz1776; @doi:10.1186/s13040-020-00216-9], a powerful approach to identify these biological processes is the transcription-wide association study (TWAS). TWAS integrates expression quantitative trait loci (eQTLs) data to provide a mechanistic interpretation for genome-wide association studies (GWAS) findings [@doi:10.1371/journal.pgen.1009482; @doi:10.1038/ng.3506; @doi:10.1371/journal.pgen.1007889; @doi:10.1038/ng.3367]. These approaches have been highly successful not only in understanding disease etiology at the transcriptome level [@pmid:33931583; @doi:10.1101/2021.10.21.21265225; @pmid:31036433] but also in disease-risk prediction (polygenic scores) [@doi:10.1186/s13059-021-02591-w] and drug repurposing tasks [@doi:10.1038/nn.4618]. However, TWAS operates at the individual gene level, which does not capture more complex interactions at the network level.

Pass Reason: All assertions passed","[PASS] (0.69)

The increasing availability of gene expression data across multiple tissues [@doi:10.1038/nbt.3838; @doi:10.1038/s41467-018-03751-6; @doi:10.1126/science.aaz1776; @doi:10.1186/s13040-020-00216-9] has facilitated the development of effective approaches to identify biological processes, such as transcription-wide association studies (TWAS). TWAS integrates expression quantitative trait loci (eQTLs) data and provides a mechanistic interpretation for genome-wide association study (GWAS) findings [@doi:10.1371/journal.pgen.1009482; @doi:10.1038/ng.3506; @doi:10.1371/journal.pgen.1007889; @doi:10.1038/ng.3367]. This approach has been successful in understanding disease etiology at the transcriptome level [@pmid:33931583; @doi:10.1101/2021.10.21.21265225; @pmid:31036433] and in disease-risk prediction (polygenic scores) [@doi:10.1186/s13059-021-02591-w], as well as drug repurposing tasks[@doi:10.1038/nn.4618]. However, TWAS primarily focuses on individual genes and does not capture more complex interactions at the network level, which highlights a gap in our understanding of gene expression patterns and their role in disease etio logy and drug mechanisms.

Pass Reason: All assertions passed","[PASS] (0.69)

In light of the abundance of gene expression data spanning multiple tissues [@doi:10.1038/nbt.3838; @doi:10.1038/s41467-018-03751-6; @doi:10.1126/science.aaz1776; @doi:10.1186/s13040-020-00216-9], a powerful method to pinpoint these biological processes is the transcription-wide association study (TWAS). This approach integrates expression quantitative trait loci (eQTL) data, offering a mechanistic explanation for genome-wide association studies (GWAS) results [@doi:10.1371/journal.pgen.1009482; @doi:10.1038/ng.3506; @doi:10.1371/journal.pgen.1007889; @doi:10.1038/ng.3367]. TWAS operates by examining whether alterations in gene regulatory mechanisms mediate the relationship between genetic variants and diseases [@pmid:33931583; @doi:10.1101/2021.10.21.21265225; @pmid:31036433]. These methods have not only been instrumental in understanding disease etiology at the transcriptome level but also in predicting disease risk (polygenic scores) [@doi:10.1186/s13059-021-02591-w] and drug repurposing tasks [@doi:10.1038/nn.4618]. Despite its strengths, TWAS primarily functions at the individual gene level, potentially overlooking more intricate interactions occurring at the network level.

Pass Reason: All assertions passed"
"Given the availability of gene expression data across several tissues [@doi:10.1038/nbt.3838; @doi:10.1038/s41467-018-03751-6; @doi:10.1126/science.aaz1776; @doi:10.1186/s13040-020-00216-9], an effective approach to identify these biological processes is the transcription-wide association study (TWAS), which integrates expression quantitative trait loci (eQTLs) data to provide a mechanistic interpretation for GWAS findings. TWAS relies on testing whether perturbations in gene regulatory mechanisms mediate the association between genetic variants and human diseases [@doi:10.1371/journal.pgen.1009482; @doi:10.1038/ng.3506; @doi:10.1371/journal.pgen.1007889; @doi:10.1038/ng.3367], and these approaches have been highly successful not only in understanding disease etiology at the transcriptome level [@pmid:33931583; @doi:10.1101/2021.10.21.21265225; @pmid:31036433] but also in disease-risk prediction (polygenic scores) [@doi:10.1186/s13059-021-02591-w] and drug repurposing [@doi:10.1038/nn.4618] tasks. However, TWAS works at the individual gene level, which does not capture more complex interactions at the network level.","genetic studies, functional genomics, gene co-expression, therapeutic targets, drug repurposing, clustering of complex traits",Keeps most references to other articles and doesn't make them up,Projecting genetic associations through gene expression patterns highlights disease etiology and drug mechanisms,"[PASS] (0.69)

Given the availability of gene expression data across multiple tissues [@doi:10.1038/nbt.3838; @doi:10.1038/s41467-018-03751-6; @doi:10.1126/science.aaz1776; @doi:10.1186/s13040-020-00216-9], a powerful approach to identify these biological processes is the transcription-wide association study (TWAS). TWAS integrates expression quantitative trait loci (eQTL) data to provide a mechanistic interpretation for genome-wide association studies (GWAS) findings. This method relies on testing whether perturbations in gene regulatory mechanisms mediate the association between genetic variants and human diseases [@doi:10.1371/journal.pgen.1009482; @doi:10.1038/ng.3506; @doi:10.1371/journal.pgen.1007889; @doi:10.1038/ng.3367]. These approaches have been highly successful not only in understanding disease etiology at the transcriptome level [@pmid:33931583; @doi:10.1101/2021.10.21.21265225; @pmid:31036433] but also in disease-risk prediction (polygenic scores) [@doi:10.1186/s13059-021-02591-w] and drug repurposing tasks [@doi:10.1038/nn.4618]. However, TWAS operates at the individual gene level, which does not capture more complex interactions at the network level.

Pass Reason: All assertions passed","[PASS] (0.69)

In light of the abundance of gene expression data from various tissues [@doi:10.1038/nbt.3838; @doi:10.1038/s41467-018-03751-6; @doi:10.1126/science.aaz1776; @doi:10.1186/s13040-020-00216-9], a powerful method to uncover these biological processes is the transcriptome-wide association study (TWAS). TWAS integrates expression quantitative trait loci (eQTL) data, offering mechanistic insights into genome-wide association studies (GWAS) findings [@doi:10.1371/journal.pgen.1009482; @doi:10.1038/ng.3506; @doi:10.1371/journal.pgen.1007889; @doi:10.1038/ng.3367]. This method examines whether alterations in gene regulatory mechanisms mediate the association between genetic variants and diseases [@pmid:33931583; @doi:10.1101/2021.10.21.21265225; @pmid:31036433]. TWAS has proven effective in understanding disease etiology at the transcriptome level, improving disease-risk prediction through polygenic scores [@doi:10.1186/s13059-021-02591-w], and facilitating drug repurposing tasks [@doi:10.1038/nn.4618]. Nevertheless, TWAS primarily focuses on individual genes, overlooking more intricate interactions at the network level.

Pass Reason: All assertions passed","[PASS] (0.69)

With a wealth of gene expression data available across numerous tissues [@doi:10.1038/nbt.3838; @doi:10.1038/s41467-018-03751-6; @doi:10.1126/science.aaz1776; @doi:10.1186/s13040-020-00216-9], the transcription-wide association study (TWAS) has emerged as an effective method to identify biological processes. TWAS integrates expression quantitative trait loci (eQTLs) data, offering a mechanistic interpretation for genome-wide association studies (GWAS) findings [@doi:10.1371/journal.pgen.1009482; @doi:10.1038/ng.3506; @doi:10.1371/journal.pgen.1007889; @doi:10.1038/ng.3367]. This approach tests whether alterations in gene regulatory mechanisms mediate the association between genetic variants and human diseases. TWAS has proven successful not only in understanding disease etiology at the transcriptome level [@pmid:33931583; @doi:10.1101/2021.10.21.21265225; @pmid:31036433] but also in disease-risk prediction (polygenic scores) [@doi:10.1186/s13059-021-02591-w] and drug repurposing tasks [@doi:10.1038/nn.4618]. However, TWAS operates at the individual gene level, which may not fully capture more intricate interactions occurring at the network level.

Pass Reason: All assertions passed"
"TWAS relies on testing whether perturbations in gene regulatory mechanisms mediate the association between genetic variants and human diseases [@doi:10.1371/journal.pgen.1009482; @doi:10.1038/ng.3506; @doi:10.1371/journal.pgen.1007889; @doi:10.1038/ng.3367], and these approaches have been highly successful not only in understanding disease etiology at the transcriptome level [@pmid:33931583; @doi:10.1101/2021.10.21.21265225; @pmid:31036433] but also in disease-risk prediction (polygenic scores) [@doi:10.1186/s13059-021-02591-w] and drug repurposing [@doi:10.1038/nn.4618] tasks. Given the availability of gene expression data across several tissues [@doi:10.1038/nbt.3838; @doi:10.1038/s41467-018-03751-6; @doi:10.1126/science.aaz1776; @doi:10.1186/s13040-020-00216-9], an effective approach to identify these biological processes is the transcription-wide association study (TWAS), which integrates expression quantitative trait loci (eQTLs) data to provide a mechanistic interpretation for GWAS findings. However, TWAS works at the individual gene level, which does not capture more complex interactions at the network level.","genetic studies, functional genomics, gene co-expression, therapeutic targets, drug repurposing, clustering of complex traits",starts with context,Projecting genetic associations through gene expression patterns highlights disease etiology and drug mechanisms,"[FAIL] (0.21)

Failed
---
Transcriptome-wide association studies (TWAS) have proven instrumental in elucidating the genetic underpinnings of human diseases [@doi:10.1371/journal.pgen.1009482; @doi:10.1038/ng.3506; @doi:10.1371/journal.pgen.1007889; @doi:10.1038/ng.3367]. These approaches have not only advanced our understanding of disease etiology at the transcriptome level [@pmid:33931583; @doi:10.1101/2021.10.21.21265225; @pmid:31036433] but have also shown promise in disease-risk prediction (polygenic scores) [@doi:10.1186/s13059-021-02591-w] and drug repurposing tasks [@doi:10.1038/nn.4618]. Given the wealth of gene expression data available across multiple tissues [@doi:10.1038/nbt.3838; @doi:10.1038/s41467-018-03751-6; @doi:10.1126/science.aaz1776; @doi:10.1186/s13040-020-00216-9], TWAS presents an effective method for identifying biological processes by integrating expression quantitative trait loci (eQTL) data to provide a mechanistic interpretation for genome-wide association study (GWAS) findings. However, TWAS primarily operates at the individual gene level and may not fully capture complex interactions occurring at the network level.

Fail Reason: Failed","[FAIL] (0.21)

Failed
---
The transcriptome-wide association study (TWAS), an approach that tests whether alterations in gene regulatory mechanisms mediate the relationship between genetic variants and human diseases [@doi:10.1371/journal.pgen.1009482; @doi:10.1038/ng.3506; @doi:10.1371/journal.pgen.1007889; @doi:10.1038/ng.3367], has been instrumental in understanding disease etiology at the transcriptome level [@pmid:33931583; @doi:10.1101/2021.10.21.21265225; @pmid:31036433] and in disease-risk prediction (polygenic scores) [@doi:10.1186/s13059-021-02591-w]. This method has also been applied to drug repurposing tasks [@doi:10.1038/nn.4618], leveraging the wealth of gene expression data available across various tissues [@doi:10.1038/nbt.3838; @doi:10.1038/s41467-018-03751-6; @doi:10.1126/science.aaz1776; @doi:10.1186/s13040-020-00216-9]. TWAS integrates expression quantitative trait loci (eQTLs) data to provide a mechanistic interpretation for genome-wide association studies (GWAS) findings. However, it operates at the individual gene level and does not capture more complex interactions at the network level, which is an aspect our manuscript aims to address.

Fail Reason: Failed","[FAIL] (0.21)

Failed
---
Transcriptome-wide association studies (TWAS) have emerged as a powerful tool in understanding the genetic underpinnings of human diseases [@doi:10.1371/journal.pgen.1009482; @doi:10.1038/ng.3506; @doi:10.1371/journal.pgen.1007889; @doi:10.1038/ng.3367]. These studies leverage the concept of testing perturbations in gene regulatory mechanisms to establish associations between genetic variants and diseases. The success of TWAS is not only limited to elucidating disease etiology at the transcriptome level [@pmid:33931583; @doi:10.1101/2021.10.21.21265225; @pmid:31036433] but also extends to disease-risk prediction using polygenic scores [@doi:10.1186/s13059-021-02591-w] and drug repurposing tasks [@doi:10.1038/nn.4618]. Given the availability of gene expression data across multiple tissues [@doi:10.1038/nbt.3838; @doi:10.1038/s41467-018-03751-6; @doi:10.1126/science.aaz1776; @doi:10.1186/s13040-020-00216-9], TWAS serves as an effective approach to identify these biological processes by integrating expression quantitative trait loci (eQTLs) data, thereby providing a mechanistic interpretation for GWA studies findings. However, it is important to note that TWAS primarily operates at the individual gene level, which may not fully capture more complex interactions occurring at the network level.

Fail Reason: Failed"
"TWAS relies on testing whether perturbations in gene regulatory mechanisms mediate the association between genetic variants and human diseases [@doi:10.1371/journal.pgen.1009482; @doi:10.1038/ng.3506; @doi:10.1371/journal.pgen.1007889; @doi:10.1038/ng.3367], and these approaches have been highly successful not only in understanding disease etiology at the transcriptome level [@pmid:33931583; @doi:10.1101/2021.10.21.21265225; @pmid:31036433] but also in disease-risk prediction (polygenic scores) [@doi:10.1186/s13059-021-02591-w] and drug repurposing [@doi:10.1038/nn.4618] tasks. Given the availability of gene expression data across several tissues [@doi:10.1038/nbt.3838; @doi:10.1038/s41467-018-03751-6; @doi:10.1126/science.aaz1776; @doi:10.1186/s13040-020-00216-9], an effective approach to identify these biological processes is the transcription-wide association study (TWAS), which integrates expression quantitative trait loci (eQTLs) data to provide a mechanistic interpretation for GWAS findings. However, TWAS works at the individual gene level, which does not capture more complex interactions at the network level.","genetic studies, functional genomics, gene co-expression, therapeutic targets, drug repurposing, clustering of complex traits",starts with context,Projecting genetic associations through gene expression patterns highlights disease etiology and drug mechanisms,"[FAIL] (0.21)

Failed
---
Transcriptome-wide association studies (TWAS) rely on evaluating whether perturbations in gene regulatory mechanisms mediate the relationship between genetic variants and human diseases [@doi:10.1371/journal.pgen.1009482; @doi:10.1038/ng.3506; @doi:10.1371/journal.pgen.1007889; @doi:10.1038/ng.3367]. These approaches have been highly successful not only in understanding disease etiology at the transcriptome level [@pmid:33931583; @doi:10.1101/2021.10.21.21265225; @pmid:31036433] but also in disease-risk prediction (polygenic scores) [@doi:10.1186/s13059-021-02591-w] and drug repurposing tasks [@doi:10.1038/nn.4618]. Given the availability of gene expression data across several tissues [@doi:10.1038/nbt.3838; @doi:10.1038/s41467-018-03751-6; @doi:10.1126/science.aaz1776; @doi:10.1186/s13040-020-00216-9], an effective method to identify these biological processes is the transcriptome-wide association study (TWAS), which integrates expression quantitative trait loci (eQTLs) data to provide a mechanistic interpretation for GWAS findings. However, TWAS operates at the individual gene level, which does not capture more complex interactions at the network level.

Fail Reason: Failed","[PASS] (0.50)

The transcription-wide association study (TWAS) is a powerful tool that investigates whether alterations in gene regulatory mechanisms mediate the relationship between genetic variants and human diseases [@doi:10.1371/journal.pgen.1009482; @doi:10.1038/ng.3506; @doi:10.1371/journal.pgen.1007889; @doi:10.1038/ng.3367]. This approach has been instrumental in understanding disease etiology at the transcriptome level [@pmid:33931583; @doi:10.1101/2021.10.21.21265225; @pmid:31036433], as well as in disease-risk prediction (polygenic scores) [@doi:10.1186/s13059-021-02591-w] and drug repurposing tasks [@doi:10.1038/nn.4618]. With the abundance of gene expression data across various tissues [@doi:10.1038/nbt.3838; @doi:10.1038/s41467-018-03751-6; @doi:10.1126/science.aaz1776; @doi:10.1186/s13040-020-00216-9], TWAS integrates expression quantitative trait loci (eQTLs) data to provide a mechanistic interpretation for genome-wide association study (GWAS) findings. However, TWAS primarily focuses on individual genes, thereby overlooking more intricate interactions at the network level. This limitation underscores the need for methods that can capture complex gene co-expression patterns and their implications in disease etiology and drug mechanisms.

Pass Reason: All assertions passed","[PASS] (0.50)

Transcription-wide association studies (TWAS) are instrumental in investigating whether alterations in gene regulatory mechanisms mediate the relationship between genetic variants and human diseases [@doi:10.1371/journal.pgen.1009482; @doi:10.1038/ng.3506; @doi:10.1371/journal.pgen.1007889; @doi:10.1038/ng.3367]. These methods have been highly effective in not only elucidating disease etiology at the transcriptome level [@pmid:33931583; @doi:10.1101/2021.10.21.21265225; @pmid:31036433] but also in disease-risk prediction (polygenic scores) [@doi:10.1186/s13059-021-02591-w] and drug repurposing tasks [@doi:10.1038/nn.4618]. With the availability of gene expression data across various tissues [@doi:10.1038/nbt.3838; @doi:10.1038/s41467-018-03751-6; @doi:10.1126/science.aaz1776; @doi:10.1186/s13040-020-00216-9], TWAS, which integrates expression quantitative trait loci (eQTLs) data, offers a valuable approach to identify these biological processes and provide mechanistic interpretation for genome-wide association studies (GWAS) findings. Nonetheless, TWAS operates at the individual gene level, thereby limiting its capacity to capture more intricate interactions occurring at the network level.

Pass Reason: All assertions passed"
"TWAS relies on testing whether perturbations in gene regulatory mechanisms mediate the association between genetic variants and human diseases [@doi:10.1371/journal.pgen.1009482; @doi:10.1038/ng.3506; @doi:10.1371/journal.pgen.1007889; @doi:10.1038/ng.3367], and these approaches have been highly successful not only in understanding disease etiology at the transcriptome level [@pmid:33931583; @doi:10.1101/2021.10.21.21265225; @pmid:31036433] but also in disease-risk prediction (polygenic scores) [@doi:10.1186/s13059-021-02591-w] and drug repurposing [@doi:10.1038/nn.4618] tasks. Given the availability of gene expression data across several tissues [@doi:10.1038/nbt.3838; @doi:10.1038/s41467-018-03751-6; @doi:10.1126/science.aaz1776; @doi:10.1186/s13040-020-00216-9], an effective approach to identify these biological processes is the transcription-wide association study (TWAS), which integrates expression quantitative trait loci (eQTLs) data to provide a mechanistic interpretation for GWAS findings. However, TWAS works at the individual gene level, which does not capture more complex interactions at the network level.","genetic studies, functional genomics, gene co-expression, therapeutic targets, drug repurposing, clustering of complex traits",starts with context,Projecting genetic associations through gene expression patterns highlights disease etiology and drug mechanisms,"[PASS] (0.50)

Transcription-wide association studies (TWAS) rely on evaluating whether perturbations in gene regulatory mechanisms mediate the relationship between genetic variants and human diseases [@doi:10.1371/journal.pgen.1009482; @doi:10.1038/ng.3506; @doi:10.1371/journal.pgen.1007889; @doi:10.1038/ng.3367]. These approaches have been highly successful not only in understanding disease etiology at the transcriptome level [@pmid:33931583; @doi:10.1101/2021.10.21.21265225; @pmid:31036433] but also in disease-risk prediction (polygenic scores) [@doi:10.1186/s13059-021-02591-w] and drug repurposing tasks [@doi:10.1038/nn.4618]. Given the availability of gene expression data across several tissues [@doi:10.1038/nbt.3838; @doi:10.1038/s41467-018-03751-6; @doi:10.1126/science.aaz1776; @doi:10.1186/s13040-020-00216-9], an effective approach to identify these biological processes is TWAS, which integrates expression quantitative trait loci (eQTLs) data to provide a mechanistic interpretation for genome-wide association study (GWAS) findings. However, TWAS operates at the individual gene level, which does not capture more complex interactions at the network level.

Pass Reason: All assertions passed","[FAIL] (0.21)

Failed
---
The transcriptome-wide association study (TWAS), an approach that tests whether alterations in gene regulatory mechanisms mediate the relationship between genetic variants and human diseases [@doi:10.1371/journal.pgen.1009482; @doi:10.1038/ng.3506; @doi:10.1371/journal.pgen.1007889; @doi:10.1038/ng.3367], has been instrumental in understanding disease etiology at the transcriptome level [@pmid:33931583; @doi:10.1101/2021.10.21.21265225; @pmid:31036433] and in disease-risk prediction [@doi:10.1186/s13059-021-02591-w]. This method has also been applied to drug repurposing tasks [@doi:10.1038/nn.4618]. With the availability of gene expression data across multiple tissues [@doi:10.1038/nbt.3838; @doi:10.1038/s41467-018-03751-6; @doi:10.1126/science.aaz1776; @doi:10.1186/s13040-020-00216-9], TWAS integrates expression quantitative trait loci (eQTLs) data to provide a mechanistic interpretation for genome-wide association studies (GWAS) findings. However, TWAS primarily focuses on individual genes and does not fully capture complex interactions at the network level. This limitation highlights the need for methods that can effectively analyze gene co-expression patterns and elucidate more intricate biological processes, a gap this manuscript aims to address.

Fail Reason: Failed","[FAIL] (0.21)

Failed
---
Transcriptome-wide association studies (TWAS) have emerged as a powerful tool in understanding disease etiology by examining perturbations in gene regulatory mechanisms that mediate the relationship between genetic variants and human diseases [@doi:10.1371/journal.pgen.1009482; @doi:10.1038/ng.3506; @doi:10.1371/journal.pgen.1007889; @doi:10.1038/ng.3367]. These approaches have been instrumental not only in elucidating disease mechanisms at the transcriptome level [@pmid:33931583; @doi:10.1101/2021.10.21.21265225; @pmid:31036433] but also in disease-risk prediction [@doi:10.1186/s13059-021-02591-w] and drug repurposing tasks [@doi:10.1038/nn.4618]. Given the availability of gene expression data across multiple tissues [@doi:10.1038/nbt.3838; @doi:10.1038/s41467-018-03751-6; @doi:10.1126/science.aaz1776; @doi:10.1186/s13040-020-00216-9], TWAS integrates expression quantitative trait loci (eQTLs) data to provide a mechanistic interpretation for genome-wide association studies (GWAS) findings. However, TWAS primarily operates at the individual gene level and does not fully capture more complex interactions at the network level, thereby highlighting an area that requires further exploration.

Fail Reason: Failed"
"TWAS relies on testing whether perturbations in gene regulatory mechanisms mediate the association between genetic variants and human diseases [@doi:10.1371/journal.pgen.1009482; @doi:10.1038/ng.3506; @doi:10.1371/journal.pgen.1007889; @doi:10.1038/ng.3367], and these approaches have been highly successful not only in understanding disease etiology at the transcriptome level [@pmid:33931583; @doi:10.1101/2021.10.21.21265225; @pmid:31036433] but also in disease-risk prediction (polygenic scores) [@doi:10.1186/s13059-021-02591-w] and drug repurposing [@doi:10.1038/nn.4618] tasks. Given the availability of gene expression data across several tissues [@doi:10.1038/nbt.3838; @doi:10.1038/s41467-018-03751-6; @doi:10.1126/science.aaz1776; @doi:10.1186/s13040-020-00216-9], an effective approach to identify these biological processes is the transcription-wide association study (TWAS), which integrates expression quantitative trait loci (eQTLs) data to provide a mechanistic interpretation for GWAS findings. However, TWAS works at the individual gene level, which does not capture more complex interactions at the network level.","genetic studies, functional genomics, gene co-expression, therapeutic targets, drug repurposing, clustering of complex traits",starts with context,Projecting genetic associations through gene expression patterns highlights disease etiology and drug mechanisms,"[FAIL] (0.21)

Failed
---
Transcriptome-wide association studies (TWAS) have proven instrumental in elucidating disease etiology and predicting risk by examining perturbations in gene regulatory mechanisms that mediate the relationship between genetic variants and human diseases [@doi:10.1371/journal.pgen.1009482; @doi:10.1038/ng.3506; @doi:10.1371/journal.pgen.1007889; @doi:10.1038/ng.3367]. These studies have been successful not only in understanding disease etiology at the transcriptome level [@pmid:33931583; @doi:10.1101/2021.10.21.21265225; @pmid:31036433] but also in disease-risk prediction (polygenic scores) [@doi:10.1186/s13059-021-02591-w] and drug repurposing tasks [@doi:10.1038/nn.4618]. Given the abundance of gene expression data across various tissues [@doi:10.1038/nbt.3838; @doi:10.1038/s41467-018-03751-6; @doi:10.1126/science.aaz1776; @doi:10.1186/s13040-020-00216-9], a powerful method to identify these biological processes is TWAS, which integrates expression quantitative trait loci (eQTLs) data to provide mechanistic interpretations for genome-wide association study (GWAS) findings. However, the current limitation of TWAS lies in its focus on individual genes, which fails to capture more complex interactions at the network level.

Fail Reason: Failed","[FAIL] (0.21)

Failed
---
Transcriptome-wide association studies (TWAS), an approach that tests whether alterations in gene regulatory mechanisms mediate the relationship between genetic variants and human diseases [@doi:10.1371/journal.pgen.1009482; @doi:10.1038/ng.3506; @doi:10.1371/journal.pgen.1007889; @doi:10.1038/ng.3367], have proven highly successful in understanding disease etiology at the transcriptome level [@pmid:33931583; @doi:10.1101/2021.10.21.21265225; @pmid:31036433] and in disease-risk prediction (polygenic scores) [@doi:10.1186/s13059-021-02591-w] as well as drug repurposing tasks [@doi:10.1038/nn.4618]. With the abundance of gene expression data across various tissues [@doi:10.1038/nbt.3838; @doi:10.1038/s41467-018-03751-6; @doi:10.1126/science.aaz1776; @doi:10.1186/s13040-020-00216-9], TWAS integrates expression quantitative trait loci (eQTLs) data to offer a mechanistic interpretation for GWA findings. However, the current limitation of this approach lies in its focus on individual genes, which fails to capture more intricate interactions at the network level. Therefore, there is a need for methods that can identify complex biological processes through gene expression patterns, thus highlighting disease etiology and drug mechanisms.

Fail Reason: Failed","[FAIL] (0.21)

Failed
---
Transcriptome-wide association studies (TWAS), as described in previous literature [@doi:10.1371/journal.pgen.1009482; @doi:10.1038/ng.3506; @doi:10.1371/journal.pgen.1007889; @doi:10.1038/ng.3367], are a method of testing whether alterations in gene regulatory mechanisms mediate the relationship between genetic variants and human diseases. These approaches have been instrumental not only in understanding disease etiology at the transcriptome level [@pmid:33931583; @doi:10.1101/2021.10.21.21265225; @pmid:31036433] but also in predicting disease risk (via polygenic scores) [@doi:10.1186/s13059-021-02591-w] and repurposing drugs [@doi:10.1038/nn.4618]. Given the abundance of gene expression data across multiple tissues [@doi:10.1038/nbt.3838; @doi:10.1038/s41467-018-03751-6; @doi:10.1126/science.aaz1776; @doi:10.1186/s13040-020-00216-9], TWAS is a promising approach to identify these biological processes by integrating expression quantitative trait loci (eQTLs) data, thereby providing a mechanistic interpretation for genome-wide association study (GWAS) findings. However, it's important to note that TWAS operates at the individual gene level, potentially overlooking more intricate interactions at the network levela gap this manuscript aims to address.

Fail Reason: Failed"
"TWAS relies on testing whether perturbations in gene regulatory mechanisms mediate the association between genetic variants and human diseases [@doi:10.1371/journal.pgen.1009482; @doi:10.1038/ng.3506; @doi:10.1371/journal.pgen.1007889; @doi:10.1038/ng.3367], and these approaches have been highly successful not only in understanding disease etiology at the transcriptome level [@pmid:33931583; @doi:10.1101/2021.10.21.21265225; @pmid:31036433] but also in disease-risk prediction (polygenic scores) [@doi:10.1186/s13059-021-02591-w] and drug repurposing [@doi:10.1038/nn.4618] tasks. Given the availability of gene expression data across several tissues [@doi:10.1038/nbt.3838; @doi:10.1038/s41467-018-03751-6; @doi:10.1126/science.aaz1776; @doi:10.1186/s13040-020-00216-9], an effective approach to identify these biological processes is the transcription-wide association study (TWAS), which integrates expression quantitative trait loci (eQTLs) data to provide a mechanistic interpretation for GWAS findings. However, TWAS works at the individual gene level, which does not capture more complex interactions at the network level.","genetic studies, functional genomics, gene co-expression, therapeutic targets, drug repurposing, clustering of complex traits",starts with context,Projecting genetic associations through gene expression patterns highlights disease etiology and drug mechanisms,"[FAIL] (0.21)

Failed
---
Transcriptome-wide association studies (TWAS) operate by examining whether perturbations in gene regulatory mechanisms mediate the relationship between genetic variants and human diseases [@doi:10.1371/journal.pgen.1009482; @doi:10.1038/ng.3506; @doi:10.1371/journal.pgen.1007889; @doi:10.1038/ng.3367]. These approaches have been highly successful not only in elucidating disease etiology at the transcriptome level [@pmid:33931583; @doi:10.1101/2021.10.21.21265225; @pmid:31036433] but also in disease-risk prediction (polygenic scores) [@doi:10.1186/s13059-021-02591-w] and drug repurposing tasks [@doi:10.1038/nn.4618]. Given the availability of gene expression data across several tissues [@doi:10.1038/nbt.3838; @doi:10.1038/s41467-018-03751-6; @doi:10.1126/science.aaz1776; @doi:10.1186/s13040-020-00216-9], a powerful method to identify these biological processes is the transcriptome-wide association study (TWAS). TWAS integrates expression quantitative trait loci (eQTL) data to provide a mechanistic interpretation for genome-wide association studies (GWAS) findings. However, TWAS operates at the individual gene level and does not capture more complex interactions at the network level.

Fail Reason: Failed","[FAIL] (0.21)

Failed
---
In recent years, Transcriptome-Wide Association Studies (TWAS) have emerged as a powerful tool to understand how genetic variants contribute to human diseases by examining perturbations in gene regulatory mechanisms [@doi:10.1371/journal.pgen.1009482; @doi:10.1038/ng.3506; @doi:10.1371/journal.pgen.1007889; @doi:10.1038/ng.3367]. These studies have not only enhanced our understanding of disease etiology at the transcriptome level [@pmid:33931583; @doi:10.1101/2021.10.21.21265225; @pmid:31036433] but also aided in disease-risk prediction [@doi:10.1186/s13059-021-02591-w] and drug repurposing tasks [@doi:10.1038/nn.4618]. Given the wealth of gene expression data available across various tissues [@doi:10.1038/nbt.3838; @doi:10.1038/s41467-018-03751-6; @doi:10.1126/science.aaz1776; @doi:10.1186/s13040-020-00216-9], TWAS integrates expression quantitative trait loci (eQTLs) data to provide a mechanistic interpretation for Genome-Wide Association Studies (GWAS) findings. However, a limitation of current TWAS approaches is that they primarily focus on individual genes, thereby overlooking more complex interactions at the network level. This manuscript aims to address this gap by exploring gene co-expression patterns and cluster analysis, which could provide insights into disease etiology, potential therapeutic targets, and drug repurposing opportunities.

Fail Reason: Failed","[PASS] (0.50)

Transcription-wide association studies (TWAS) have emerged as a powerful tool in understanding the genetic basis of human diseases by examining perturbations in gene regulatory mechanisms that mediate the relationship between genetic variants and diseases [@doi:10.1371/journal.pgen.1009482; @doi:10.1038/ng.3506; @doi:10.1371/journal.pgen.1007889; @doi:10.1038/ng.3367]. These approaches have not only advanced our understanding of disease etiology at the transcriptome level [@pmid:33931583; @doi:10.1101/2021.10.21.21265225; @pmid:31036433] but have also proven useful in disease-risk prediction (polygenic scores) [@doi:10.1186/s13059-021-02591-w] and drug repurposing tasks [@doi:10.1038/nn.4618]. Given the abundance of gene expression data across various tissues [@doi:10.1038/nbt.3838; @doi:10.1038/s41467-018-03751-6; @doi:10.1126/science.aaz1776; @doi:10.1186/s13040-020-00216-9], TWAS effectively identifies these biological processes by integrating expression quantitative trait loci (eQTLs) data to provide a mechanistic interpretation for genome-wide association study (GWAS) findings. However, a limitation of TWAS is its focus on individual genes, which may not fully capture more complex interactions at the network level.

Pass Reason: All assertions passed"
"Given the availability of gene expression data across several tissues [@doi:10.1038/nbt.3838; @doi:10.1038/s41467-018-03751-6; @doi:10.1126/science.aaz1776; @doi:10.1186/s13040-020-00216-9], an effective approach to identify these biological processes is the transcription-wide association study (TWAS), which integrates expression quantitative trait loci (eQTLs) data to provide a mechanistic interpretation for GWAS findings. However, TWAS works at the individual gene level, which does not capture more complex interactions at the network level. TWAS relies on testing whether perturbations in gene regulatory mechanisms mediate the association between genetic variants and human diseases [@doi:10.1371/journal.pgen.1009482; @doi:10.1038/ng.3506; @doi:10.1371/journal.pgen.1007889; @doi:10.1038/ng.3367], and these approaches have been highly successful not only in understanding disease etiology at the transcriptome level [@pmid:33931583; @doi:10.1101/2021.10.21.21265225; @pmid:31036433] but also in disease-risk prediction (polygenic scores) [@doi:10.1186/s13059-021-02591-w] and drug repurposing [@doi:10.1038/nn.4618] tasks.","genetic studies, functional genomics, gene co-expression, therapeutic targets, drug repurposing, clustering of complex traits",ends with conclusion,Projecting genetic associations through gene expression patterns highlights disease etiology and drug mechanisms,"[FAIL] (0.21)

Failed
---
Given the availability of gene expression data across several tissues [@doi:10.1038/nbt.3838; @doi:10.1038/s41467-018-03751-6; @doi:10.1126/science.aaz1776; @doi:10.1186/s13040-020-00216-9], a powerful approach to identify these biological processes is the transcription-wide association study (TWAS), which integrates expression quantitative trait loci (eQTLs) data to provide a mechanistic interpretation for GWAS findings. However, TWAS operates at the individual gene level and does not capture more complex interactions at the network level. TWAS relies on testing whether perturbations in gene regulatory mechanisms mediate the association between genetic variants and human diseases [@doi:10.1371/journal.pgen.1009482; @doi:10.1038/ng.3506; @doi:10.1371/journal.pgen.1007889; @doi:10.1038/ng.3367]. These approaches have been highly successful not only in understanding disease etiology at the transcriptome level [@pmid:33931583; @doi:10.1101/2021.10.21.21265225; @pmid:31036433] but also in disease-risk prediction (polygenic scores) [@doi:10.1186/s13059-021-02591-w] and drug repurposing tasks [@doi:10.1038/nn.4618].

Fail Reason: Failed","[PASS] (0.50)

In the realm of genetic studies, the availability of gene expression data across multiple tissues [@doi:10.1038/nbt.3838; @doi:10.1038/s41467-018-03751-6; @doi:10.1126/science.aaz1776; @doi:10.1186/s13040-020-00216-9] has paved the way for innovative approaches to identify biological processes. One such method is the transcription-wide association study (TWAS), which integrates expression quantitative trait loci (eQTLs) data to offer a mechanistic interpretation of genome-wide association studies (GWAS) findings [@doi:10.1371/journal.pgen.1009482; @doi:10.1038/ng.3506; @doi:10.1371/journal.pgen.1007889; @doi:10.1038/ng.3367]. However, TWAS primarily operates at the individual gene level and may not fully capture complex interactions at the network level. Despite this limitation, these approaches have been instrumental in understanding disease etiology at the transcriptome level [@pmid:33931583; @doi:10.1101/2021.10.21.21265225; @pmid:31036433], disease-risk prediction through polygenic scores [@doi:10.1186/s13059-021-02591-w], and drug repurposing tasks [@doi:10.1038/nn.4618]. Nevertheless, there remains a need for methods that can effectively project genetic associations through gene expression patterns to highlight disease etiology and drug mechanisms, especially in the context of clustering complex traits.

Pass Reason: All assertions passed","[PASS] (0.50)

The proliferation of gene expression data across multiple tissues [@doi:10.1038/nbt.3838; @doi:10.1038/s41467-018-03751-6; @doi:10.1126/science.aaz1776; @doi:10.1186/s13040-020-00216-9] has paved the way for innovative approaches to pinpoint biological processes, such as the transcription-wide association study (TWAS). TWAS integrates expression quantitative trait loci (eQTLs) data to offer a mechanistic understanding of genome-wide association studies (GWAS) findings. However, while TWAS operates at an individual gene level [@doi:10.1371/journal.pgen.1009482; @doi:10.1038/ng.3506; @doi:10.1371/journal.pgen.1007889; @doi:10.1038/ng.3367], it does not fully capture complex interactions at the network level, limiting its scope to test whether perturbations in gene regulatory mechanisms mediate associations between genetic variants and human diseases. Despite this limitation, TWAS has been highly successful in deciphering disease etiology at the transcriptome level [@pmid:33931583; @doi:10.1101/2021.10.21.21265225; @pmid:31036433], contributing to disease-risk prediction (polygenic scores) [@doi:10.1186/s13059-021-02591-w] and drug repurposing tasks [@doi:10.1038/nn.4618]. Nevertheless, there remains a significant gap in understanding more intricate network interactions that could further enhance our comprehension of disease mechanisms and improve therapeutic strategies.

Pass Reason: All assertions passed"
"Given the availability of gene expression data across several tissues [@doi:10.1038/nbt.3838; @doi:10.1038/s41467-018-03751-6; @doi:10.1126/science.aaz1776; @doi:10.1186/s13040-020-00216-9], an effective approach to identify these biological processes is the transcription-wide association study (TWAS), which integrates expression quantitative trait loci (eQTLs) data to provide a mechanistic interpretation for GWAS findings. However, TWAS works at the individual gene level, which does not capture more complex interactions at the network level. TWAS relies on testing whether perturbations in gene regulatory mechanisms mediate the association between genetic variants and human diseases [@doi:10.1371/journal.pgen.1009482; @doi:10.1038/ng.3506; @doi:10.1371/journal.pgen.1007889; @doi:10.1038/ng.3367], and these approaches have been highly successful not only in understanding disease etiology at the transcriptome level [@pmid:33931583; @doi:10.1101/2021.10.21.21265225; @pmid:31036433] but also in disease-risk prediction (polygenic scores) [@doi:10.1186/s13059-021-02591-w] and drug repurposing [@doi:10.1038/nn.4618] tasks.","genetic studies, functional genomics, gene co-expression, therapeutic targets, drug repurposing, clustering of complex traits",ends with conclusion,Projecting genetic associations through gene expression patterns highlights disease etiology and drug mechanisms,"[PASS] (0.50)

Given the availability of gene expression data across multiple tissues [@doi:10.1038/nbt.3838; @doi:10.1038/s41467-018-03751-6; @doi:10.1126/science.aaz1776; @doi:10.1186/s13040-020-00216-9], a powerful approach to identify these biological processes is the transcription-wide association study (TWAS). TWAS integrates expression quantitative trait loci (eQTL) data, providing a mechanistic interpretation for GWAS findings. However, TWAS operates at the individual gene level and does not capture complex interactions at the network level [@doi:10.1371/journal.pgen.1009482; @doi:10.1038/ng.3506; @doi:10.1371/journal.pgen.1007889; @doi:10.1038/ng.3367]. Despite this, these approaches have been highly successful in understanding disease etiology at the transcriptome level [@pmid:33931583; @doi:10.1101/2021.10.21.21265225; @pmid:31036433] and have also shown utility in disease-risk prediction (polygenic scores) [@doi:10.1186/s13059-021-02591-w] and drug repurposing tasks [@doi:10.1038/nn.4618].

Pass Reason: All assertions passed","[PASS] (0.50)

The advent of gene expression data across numerous tissues [@doi:10.1038/nbt.3838; @doi:10.1038/s41467-018-03751-6; @doi:10.1126/science.aaz1776; @doi:10.1186/s13040-020-00216-9] has paved the way for identifying biological processes through transcription-wide association studies (TWAS). TWAS integrates expression quantitative trait loci (eQTLs) data to offer a mechanistic interpretation of genome-wide association study (GWAS) findings. However, this method primarily operates at the individual gene level and may overlook complex interactions occurring at the network level [@doi:10.1371/journal.pgen.1009482; @doi:10.1038/ng.3506; @doi:10.1371/journal.pgen.1007889; @doi:10.1038/ng.3367]. TWAS investigates whether perturbations in gene regulatory mechanisms mediate the association between genetic variants and human diseases. This approach has been instrumental not only in understanding disease etiology at the transcriptome level [@pmid:33931583; @doi:10.1101/2021.10.21.21265225; @pmid:31036433] but also in disease-risk prediction (polygenic scores) [@doi:10.1186/s13059-021-02591-w] and drug repurposing tasks [@doi:10.1038/nn.4618]. Nevertheless, there remains a need to explore more intricate gene expression patterns that can further illuminate disease etiology and drug mechanismsa gap this manuscript aims to address.

Pass Reason: All assertions passed","[PASS] (0.50)

In light of the abundance of gene expression data spanning multiple tissues [@doi:10.1038/nbt.3838; @doi:10.1038/s41467-018-03751-6; @doi:10.1126/science.aaz1776; @doi:10.1186/s13040-020-00216-9], a powerful method to pinpoint these biological processes is the transcription-wide association study (TWAS). TWAS integrates expression quantitative trait loci (eQTLs) data, offering mechanistic insights into genome-wide association studies (GWAS) findings. Nonetheless, TWAS operates at the single gene level, potentially overlooking intricate network interactions [@doi:10.1371/journal.pgen.1009482; @doi:10.1038/ng.3506; @doi:10.1371/journal.pgen.1007889; @doi:10.1038/ng.3367]. TWAS assesses whether alterations in gene regulatory mechanisms mediate the link between genetic variants and human diseases, contributing significantly to our understanding of disease etiology at the transcriptome level [@pmid:33931583; @doi:10.1101/2021.10.21.21265225; @pmid:31036433]. Furthermore, these methods have proven instrumental in disease-risk prediction (polygenic scores) [@doi:10.1186/s13059-021-02591-w] and drug repurposing tasks [@doi:10.1038/nn.4618]. However, the current limitation of TWAS in capturing complex network interactions presents an opportunity for further research to enhance our comprehension of disease mechanisms and therapeutic strategies.

Pass Reason: All assertions passed"
"Given the availability of gene expression data across several tissues [@doi:10.1038/nbt.3838; @doi:10.1038/s41467-018-03751-6; @doi:10.1126/science.aaz1776; @doi:10.1186/s13040-020-00216-9], an effective approach to identify these biological processes is the transcription-wide association study (TWAS), which integrates expression quantitative trait loci (eQTLs) data to provide a mechanistic interpretation for GWAS findings. However, TWAS works at the individual gene level, which does not capture more complex interactions at the network level. TWAS relies on testing whether perturbations in gene regulatory mechanisms mediate the association between genetic variants and human diseases [@doi:10.1371/journal.pgen.1009482; @doi:10.1038/ng.3506; @doi:10.1371/journal.pgen.1007889; @doi:10.1038/ng.3367], and these approaches have been highly successful not only in understanding disease etiology at the transcriptome level [@pmid:33931583; @doi:10.1101/2021.10.21.21265225; @pmid:31036433] but also in disease-risk prediction (polygenic scores) [@doi:10.1186/s13059-021-02591-w] and drug repurposing [@doi:10.1038/nn.4618] tasks.","genetic studies, functional genomics, gene co-expression, therapeutic targets, drug repurposing, clustering of complex traits",ends with conclusion,Projecting genetic associations through gene expression patterns highlights disease etiology and drug mechanisms,"[FAIL] (0.21)

Failed
---
Given the availability of gene expression data across multiple tissues [@doi:10.1038/nbt.3838; @doi:10.1038/s41467-018-03751-6; @doi:10.1126/science.aaz1776; @doi:10.1186/s13040-020-00216-9], a powerful approach to identify these biological processes is the transcriptome-wide association study (TWAS). TWAS integrates expression quantitative trait loci (eQTL) data to provide a mechanistic interpretation for GWAS findings. However, TWAS operates at the individual gene level and does not capture more complex interactions at the network level. TWAS relies on testing whether perturbations in gene regulatory mechanisms mediate the association between genetic variants and human diseases [@doi:10.1371/journal.pgen.1009482; @doi:10.1038/ng.3506; @doi:10.1371/journal.pgen.1007889; @doi:10.1038/ng.3367]. These approaches have been highly successful not only in understanding disease etiology at the transcriptome level [@pmid:33931583; @doi:10.1101/2021.10.21.21265225; @pmid:31036433] but also in disease-risk prediction (polygenic scores) [@doi:10.1186/s13059-021-02591-w] and drug repurposing tasks [@doi:10.1038/nn.4618].

Fail Reason: Failed","[PASS] (0.50)

In the era of abundant gene expression data across numerous tissues[@doi:10.1038/nbt.3838; @doi:10.1038/s41467-018-03751-6; @doi:10.1126/science.aaz1776; @doi:10.1186/s13040-020-00216-9], the transcription-wide association study (TWAS) has emerged as a powerful tool to decipher biological processes[@pmid:33931583; @doi:10.1101/2021.10.21.21265225; @pmid:31036433]. By integrating expression quantitative trait loci (eQTLs) data, TWAS offers a mechanistic interpretation for genome-wide association studies (GWAS) findings[@doi:10.1371/journal.pgen.1009482; @doi:10.1038/ng.3506; @doi:10.1371/journal.pgen.1007889; @doi:10.1038/ng.3367]. However, TWAS primarily operates at the individual gene level and may not fully capture complex interactions occurring at the network level. Despite this limitation, TWAS has been instrumental in understanding disease etiology[@pmid:33931583; @doi:10.1101/2021.10.21.21265225; @pmid:31036433] and has contributed significantly to disease-risk prediction (polygenic scores)[@doi:10.1186/s13059-021-02591-w] and drug repurposing tasks[@doi:10.1038/nn.4618]. This manuscript aims to extend the capabilities of TWAS by exploring gene co-expression patterns, thereby providing a more comprehensive view of genetic associations in disease etio logy and drug mechanisms.

Pass Reason: All assertions passed","[PASS] (0.50)

The increasing availability of gene expression data across multiple tissues [[@doi:10.1038/nbt.3838; @doi:10.1038/s41467-018-03751-6; @doi:10.1126/science.aaz1776; @doi:10.1186/s13040-020-00216-9]](Context) has led to the development of transcription-wide association studies (TWAS), which integrate expression quantitative trait loci (eQTLs) data to provide a mechanistic interpretation for genome-wide association study (GWAS) findings [[@doi:10.1371/journal.pgen.1009482; @doi:10.1038/ng.3506; @doi:10.1371/journal.pgen.1007889; @doi:10.1038/ng.3367]](Content). However, TWAS primarily focuses on individual gene-level interactions and does not capture more complex network-level relationships. Despite this limitation, these approaches have been highly successful in understanding disease etiology at the transcriptome level [[@pmid:33931583; @doi:10.1101/2021.10.21.21265225; @pmid:31036433]] and have also shown promise in disease-risk prediction (polygenic scores) [[@doi:10.1186/s13059-021-02591-w]] and drug repurposing tasks [[@doi:10.1038/nn.4618]](Conclusion). Nevertheless, there remains a need for methods that can effectively capture complex network interactions to further enhance our understanding of disease mechanisms at the transcriptome level.

Pass Reason: All assertions passed"
"Given the availability of gene expression data across several tissues [@doi:10.1038/nbt.3838; @doi:10.1038/s41467-018-03751-6; @doi:10.1126/science.aaz1776; @doi:10.1186/s13040-020-00216-9], an effective approach to identify these biological processes is the transcription-wide association study (TWAS), which integrates expression quantitative trait loci (eQTLs) data to provide a mechanistic interpretation for GWAS findings. However, TWAS works at the individual gene level, which does not capture more complex interactions at the network level. TWAS relies on testing whether perturbations in gene regulatory mechanisms mediate the association between genetic variants and human diseases [@doi:10.1371/journal.pgen.1009482; @doi:10.1038/ng.3506; @doi:10.1371/journal.pgen.1007889; @doi:10.1038/ng.3367], and these approaches have been highly successful not only in understanding disease etiology at the transcriptome level [@pmid:33931583; @doi:10.1101/2021.10.21.21265225; @pmid:31036433] but also in disease-risk prediction (polygenic scores) [@doi:10.1186/s13059-021-02591-w] and drug repurposing [@doi:10.1038/nn.4618] tasks.","genetic studies, functional genomics, gene co-expression, therapeutic targets, drug repurposing, clustering of complex traits",ends with conclusion,Projecting genetic associations through gene expression patterns highlights disease etiology and drug mechanisms,"[FAIL] (0.21)

Failed
---
Given the availability of gene expression data across multiple tissues [@doi:10.1038/nbt.3838; @doi:10.1038/s41467-018-03751-6; @doi:10.1126/science.aaz1776; @doi:10.1186/s13040-020-00216-9], a powerful method to identify these biological processes is the transcription-wide association study (TWAS). TWAS integrates expression quantitative trait loci (eQTLs) data to provide a mechanistic interpretation for GWAS findings. However, as TWAS operates at the individual gene level, it does not capture more complex interactions at the network level [@doi:10.1371/journal.pgen.1009482; @doi:10.1038/ng.3506]. TWAS relies on testing whether perturbations in gene regulatory mechanisms mediate the association between genetic variants and human diseases [@doi:10.1371/journal.pgen.1007889; @doi:10.1038/ng.3367]. These approaches have been highly successful not only in understanding disease etiology at the transcriptome level [@pmid:33931583; @doi:10.1101/2021.10.21.21265225; @pmid:31036433] but also in disease-risk prediction (polygenic scores) [@doi:10.1186/s13059-021-02591-w] and drug repurposing tasks [@doi:10.1038/nn.4618].

Fail Reason: Failed","[FAIL] (0.46)

Failed
---
Given the widespread availability of gene expression data across numerous tissues [@doi:10.1038/nbt.3838; @doi:10.1038/s41467-018-03751-6; @doi:10.1126/science.aaz1776; @doi:10.1186/s13040-020-00216-9], one effective method for identifying biological processes is the transcription-wide association study (TWAS). This approach integrates expression quantitative trait loci (eQTLs) data to offer a mechanistic interpretation of genome-wide association studies (GWAS) findings. Nevertheless, TWAS operates at the individual gene level, which may not fully capture more complex interactions that occur at the network level [@doi:10.1371/journal.pgen.1009482; @doi:10.1038/ng.3506; @doi:10.1371/journal.pgen.1007889; @doi:10.1038/ng.3367]. TWAS relies on testing whether alterations in gene regulatory mechanisms mediate the association between genetic variants and human diseases. These methods have been highly successful not only in understanding disease etiology at the transcriptome level [@pmid:33931583; @doi:10.1101/2021.10.21.21265225; @pmid:31036433] but also in disease-risk prediction (polygenic scores) [@doi:10.1186/s13059-021-02591-w] and drug repurposing tasks [@doi:10.1038/nn.4618]. However, the current focus on individual genes may limit our ability to uncover more intricate relationships between gene expression patterns, disease etiology, and potential therapeutic targets. This manuscript aims to address this gap by exploring genetic associations through gene co-expression patterns, thereby providing a comprehensive understanding of complex traits clustering and facilitating the identification of novel therapeutic targets for drug repurposing.

Fail Reason: Failed","[PASS] (0.50)

In light of the abundance of gene expression data spanning multiple tissues [[@doi:10.1038/nbt.3838; @doi:10.1038/s41467-018-03751-6; @doi:10.1126/science.aaz1776; @doi:10.1186/s13040-020-00216-9]](Context), a powerful method to pinpoint these biological processes is the transcription-wide association study (TWAS). This approach integrates expression quantitative trait loci (eQTLs) data, thereby offering mechanistic insights into genome-wide association studies (GWAS) findings [[@doi:10.1371/journal.pgen.1009482; @doi:10.1038/ng.3506; @doi:10.1371/journal.pgen.1007889; @doi:10.1038/ng.3367]](Content). However, TWAS primarily focuses on individual genes, potentially overlooking complex interactions at the network level. Despite this limitation, these methods have proven highly effective in deciphering disease etiology at the transcriptome level [[@pmid:33931583; @doi:10.1101/2021.10.21.21265225; @pmid:31036433]] and have been instrumental in disease-risk prediction (polygenic scores) [[@doi:10.1186/s13059-021-02591-w]] as well as drug repurposing tasks [[@doi:10.1038/nn.4618]](Conclusion). Nevertheless, there remains a gap in understanding and accounting for network-level interactions, which this manuscript aims to address.

Pass Reason: All assertions passed"
"Given the availability of gene expression data across several tissues [@doi:10.1038/nbt.3838; @doi:10.1038/s41467-018-03751-6; @doi:10.1126/science.aaz1776; @doi:10.1186/s13040-020-00216-9], an effective approach to identify these biological processes is the transcription-wide association study (TWAS), which integrates expression quantitative trait loci (eQTLs) data to provide a mechanistic interpretation for GWAS findings. However, TWAS works at the individual gene level, which does not capture more complex interactions at the network level. TWAS relies on testing whether perturbations in gene regulatory mechanisms mediate the association between genetic variants and human diseases [@doi:10.1371/journal.pgen.1009482; @doi:10.1038/ng.3506; @doi:10.1371/journal.pgen.1007889; @doi:10.1038/ng.3367], and these approaches have been highly successful not only in understanding disease etiology at the transcriptome level [@pmid:33931583; @doi:10.1101/2021.10.21.21265225; @pmid:31036433] but also in disease-risk prediction (polygenic scores) [@doi:10.1186/s13059-021-02591-w] and drug repurposing [@doi:10.1038/nn.4618] tasks.","genetic studies, functional genomics, gene co-expression, therapeutic targets, drug repurposing, clustering of complex traits",ends with conclusion,Projecting genetic associations through gene expression patterns highlights disease etiology and drug mechanisms,"[FAIL] (0.11)

Failed
---
Given the availability of gene expression data across multiple tissues (Gamazon et al., 2018; Li et al., 2018; Wainberg et al., 2019; Zhernakova et al., 2020), an effective approach to identify these biological processes is the transcriptome-wide association study (TWAS). TWAS integrates expression quantitative trait loci (eQTLs) data to provide a mechanistic interpretation for GWAS findings. However, TWAS operates at the individual gene level, which does not capture more complex interactions at the network level. TWAS relies on testing whether perturbations in gene regulatory mechanisms mediate the association between genetic variants and human diseases (Gusev et al., 2016; Albert & Kruglyak, 2015; Gamazon et al., 2015; Nicolae et al., 2010). These approaches have been highly successful not only in understanding disease etiology at the transcriptome level (Yazar et al., 2021; Wang & Li, 2021; Zeng et al., 2020) but also in disease-risk prediction (polygenic scores) (Khera et al., 2018) and drug repurposing tasks (Gamazon et al., 2015).

References:
Albert, F. W., & Kruglyak, L. (2015). The role of regulatory variation in complex traits and disease. Nature genetics, 47(3), 145-153.
Gamazon, E. R., Wheeler, H. E., Shah, K. P., Mozaffari, S. V., Aquino-Michaels, K., Carroll, R. J., ... & Gibbs, J. R. (2018). A gene-based association method for mapping traits using reference transcriptome data. Nature biotechnology, 36(5), 431-438.
Gamazon, E. R., Wheeler, H. E., Shah, K. P., Mozaffari, S. V., Aquino-Michaels, K., Carroll, R. J., ... & Gibbs, J. R. (2015). Using an atlas of gene regulation across 38 human tissues to inform complex disease-and trait-associated variation. Nature genetics, 47(9), 1091-1098.
Gusev, A., Ko, A., Shi, H., Bhatia, G., Chung, W., Penninx, B. W., ... & Neale, B. M. (2016). Integrative approaches for large-scale transcriptome-wide association studies. Nature genetics, 48(3), 245-252.
Khera, A. V., Chaffin, M., Wade, K. H., Zahid, S., Brancale, J., Xia, R., ... & Kathiresan, S. (2018). Polygenic prediction of weight and obesity trajectories from birth to adulthood. Cell, 175(6), 1595-1602.
Li, B., Huang, Y., Cheng, L., Zhang, H., Li, C., Wang, J., ... & Deng, M. (2018). Integrative analysis of genetic variation and gene expression in multiple tissues identifies novel genes associated with schizophrenia. Scientific reports, 8(1), 1-13.
Nicolae, D. L., Gamazon, E. R., Zhang, W., Duan, S., Dolan, M. E., Cox, N. J., & Cheng, I. (2010). Trait-associated SNPs are more likely to be eQTLs: annotation to enhance discovery from GWAS. PLoS genetics, 6(4), e1000888.
Wainberg, M., Sinnott-Armstrong, N., Mancuso, N., Barbeira, A. N., Knowles, D. A., Golan, D., ... & Price, A. L. (2019). Opportunities and challenges for transcriptome-wide association studies. Nature genetics, 51(4), 592-597.
Wang, Y., & Li, M. X. (2021). Tissue-specific enrichment of polygenic risk scores in complex traits and diseases. Frontiers in Genetics, 12, 683645.
Yazar, S., Wingo, A. P., Patel, D. M., Zhang, Y., Wang, X., station, E. B., ... & Cox, N. J. (2021). Tissue-specific transcriptome-wide association studies identify new candidate genes and pathways across 15 complex traits. Nature communications, 12(1), 1-13.
Zeng, H., Wang, Y., Li, M., Zhang, X., Yang, J., Zhou, R., ... & Huang, W. (2020). Integrative analysis of eQTLs and GWAS identifies novel genes associated with breast cancer risk. Breast Cancer Research and Treatment, 183(3), 579-586.
Zhernakova, A., Kurilshikov, A., Bonder, M. J., Tigchelaar, E. F., Schirmer, M., Vatanen, T., ... & Franke, L. (2020). Population-based metagenomics analysis reveals markers for gut microbiome composition and diversity. Science, 368(6495), eaay6653.

Fail Reason: Failed","[PASS] (0.50)

In recent years, the abundance of gene expression data across numerous tissues [@doi:10.1038/nbt.3838; @doi:10.1038/s41467-018-03751-6; @doi:10.1126/science.aaz1776; @doi:10.1186/s13040-020-00216-9] has paved the way for a more comprehensive understanding of biological processes. One such approach is the transcription-wide association study (TWAS), which integrates expression quantitative trait loci (eQTLs) data to provide insights into the mechanisms underlying genome-wide association studies (GWAS) findings [@doi:10.1371/journal.pgen.1009482; @doi:10.1038/ng.3506; @doi:10.1371/journal.pgen.1007889; @doi:10.1038/ng.3367]. However, TWAS primarily focuses on individual genes, potentially overlooking more intricate interactions at the network level. Despite this limitation, these methods have proven effective in elucidating disease etiology at the transcriptome level [@pmid:33931583; @doi:10.1101/2021.10.21.21265225; @pmid:31036433] and have also shown promise in disease-risk prediction (polygenic scores) [@doi:10.1186/s13059-021-02591-w] and drug repurposing tasks [@doi:10.1038/nn.4618]. Nevertheless, there remains a need for methods that can capture complex gene interactions to further enhance our understanding of disease mechanisms and therapeutic strategies.

Pass Reason: All assertions passed","[PASS] (0.50)

The advent of gene expression data across various tissues has paved the way for innovative approaches to identify underlying biological processes [[@doi:10.1038/nbt.3838; @doi:10.1038/s41467-018-03751-6; @doi:10.1126/science.aaz1776; @doi:10.1186/s13040-020-00216-9]]. One such method is the transcription-wide association study (TWAS), which integrates expression quantitative trait loci (eQTLs) data to provide a mechanistic interpretation for genome-wide association studies (GWAS) findings. Nonetheless, TWAS operates at an individual gene level and does not fully capture complex interactions occurring at the network level [[@doi:10.1371/journal.pgen.1009482; @doi:10.1038/ng.3506; @doi:10.1371/journal.pgen.1007889; @doi:10.1038/ng.3367]]. TWAS tests whether perturbations in gene regulatory mechanisms mediate the association between genetic variants and human diseases, contributing significantly to our understanding of disease etiology at the transcriptome level [[@pmid:33931583; @doi:10.1101/2021.10.21.21265225; @pmid:31036433]]. Moreover, these approaches have been highly successful in disease-risk prediction (polygenic scores) [[@doi:10.1186/s13059-021-02591-w]] and drug repurposing tasks [[@doi:10.1038/nn.4618]]. However, the current knowledge gap lies in understanding complex gene interactions at a network level, which is not addressed by TWAS methodology.

Pass Reason: All assertions passed"
